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The aim of this research was to test the hypothesis that immune 
complexes activate mucosal mast cells to cause rapid expulsion of the 
Trichinella spiralis from the rat intestine.  Rapid expulsion is a phenomenon in 
the rat that is characterized by nearly complete elimination of a secondary 
infection.  To test this hypothesis, mast cells were cultured from bone marrow 
precursors.  These cells have a homogenous mucosal phenotype and were 
compared with the mucosal mast cell line, RBL-2H3 cells.  Each cell type was 
assayed for binding and activation by parasite specific immune complexes.  
The results showed that IgE- and IgG2a-containing immune complexes bound 
and activated RBL-2H3 cells, but only IgE significantly activated bone marrow-
derived mast cells (BMMC).  IgG1 and IgG2b immune complexes bound both 
cells types but did not trigger degranulation.  IgG2c did not bind mast cells.  
Because IgG2a-containing complexes activated RBL-2H3 cells in vitro and this 
isotype differed from other isotypes in its mechanism for induction of rapid 
expulsion, we investigated whether this isotype might activate mast cells in 
vivo.   Rats infected with Heligmosomoides polygyrus then passively 
immunized with IgG2a demonstrated rapid expulsion without significant mucus 
entrapment of larvae.  IgG2a-mediated protection was complement 
independent and Fc-dependent; however, no significant increase in RMCP-II 
release was detected during expulsion.  These results are consistent with a 
  
role for other FcR-bearing cells in IgG2a-mediated protection.  In a parallel 
investigation, confounding inflammatory factors induced by oral infection were 
eliminated by assaying rapid expulsion induced by parenteral infection.  
Protection conferred by parenteral immunization was as potent as that induced 
by natural infection was more robust than the H. polygyrus model.  
Parenterally infected rats did not display intestinal mastocytosis, eosinophilia, 
or goblet cell hyperplasia; however, mast cells were activated and mucus 
entrapment of larvae occurred at levels comparable to those observed in rats 
infected naturally.  Complement was not necessary for protection mediated by 
parenteral immunization.    
 
 
 
 
 
 
 
 
 
 
 
  
 iii
BIOGRAPHICAL SKETCH 
 
Seana Michele Thrasher was born in Fayetteville, North Carolina on 
March 13, 1970.  She attended high school in Richardson, Texas then moved 
to Holsby Brunn, Sweden for a year of divinity education at the Torchbearers 
International School.  At age eighteen, she began a Bachelor of Science in 
Biochemistry at the University of Georgia in Athens, Georgia.  After obtaining 
her B.S., she attended Colorado State University in Fort Collins, Colorado as a 
graduate student in Biochemistry.  For personal reasons, she postponed her 
Ph.D. studies and started veterinary school at the University of Georgia.  Upon 
completion of her D.V.M., she moved to Guelph, Ontario in Canada and 
pursued internship training in Large Animal Medicine and Surgery at Ontario 
Veterinary College.  She entered the Graduate Field of Comparative 
Biomedical Sciences at Cornell University in Ithaca, New York for study 
culminating in a Doctor of Philosophy. 
 
 
 
 
 
 
 
 
 
 
 
  
 iv
 
 
 
 
 
 
 
 
 
 
 
To the Eastview clinic veterinarians and to the Genny Light Barn crew who all 
made me smile on Saturdays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 v
ACKNOWLEDGEMENTS 
 
 
I would like to thank all the members of the Appleton laboratory for 
being encouraging, helpful, and most importantly for the great camaraderie 
that made our work environment a joy. 
I would like to thank Dr. Judith Appleton for her constant patience and 
excellent guidance as a mentor.  I would also like to thank my committee 
members, Dr. David Holowka, Dr. Helene Marquis, and Dr. Klaus Beyenbach 
for their research expertise and advice.  
I am indebted to the Baker Institute laboratory animal staff, without 
whose dedication this work would not have been possible, and to Lincoln 
Adams for teaching me all his technical tricks. 
I am very grateful to have been a member of the Baker Institute which 
is truly a community of dedicated scientists and wonderful people.  
I would like to acknowledge appreciation for the financial support of my 
training from the National Institutes of Health Sponsored Research 
Assistantship (T32 RR0759) and Cornell University Graduate Research 
Assistantship.  In addition, this work was supported by the National Institutes 
of Health grant AI 14490.    
 
 
 
 
 
 
  
 vi
TABLE OF CONTENTS 
 
Biographical Sketch..........................................................................................iii 
Dedication ....................................................................................................... iv 
Acknowledgements .......................................................................................... v 
Table of contents............................................................................................. vi 
List of figures ..................................................................................................viii 
 
 
CHAPTER ONE:  Introduction.......................................................................... 1 
A.  Relevance of this research ...................................................................... 2 
B.  Life-cycle of T. spiralis ............................................................................. 5 
C.  The immune response to T. spiralis ........................................................ 6 
1. Rapid expulsion of T. spiralis ................................................................ 6 
2.  The role of mast cells in immunity to T. spiralis .................................... 8 
3.  The role of increased intestinal permeability and secretion                   
in immunity to T. spiralis.......................................................................... 10 
4.  The role of muscle hypertrophy and hypercontractility                          
in immunity to T. spiralis.......................................................................... 12 
5.  The role of eosinophils in immunity to T. spiralis ................................ 13 
6.  The role of goblet cell hyperplasia and mucus entrapment                   
in immunity to T. spiralis.......................................................................... 14 
7.  The role of antibody in immunity to T. spiralis .................................... 15 
8.  The role of lymphocytes in rapid expulsion of T. spiralis .................... 17 
D.  The mucosal phenotype of rat bone marrow-derived mast cells    
(BMMC) and RBL-2H3 cells........................................................................ 18 
E.  Trichinella antigens and IgG immune complexes .................................. 19 
F.  Fc receptors........................................................................................... 20 
G.  Objectives of study................................................................................ 21 
H.  References............................................................................................ 23 
 
 
CHAPTER TWO:  Receptor binding activation of mucosal mast cells by       
IgG complexed with nematode glycoproteins ................................................. 35 
Abstract....................................................................................................... 36 
Introduction ................................................................................................. 37 
Materials and methods................................................................................ 39 
Results........................................................................................................ 45 
Discussion .................................................................................................. 56 
Acknowledgements..................................................................................... 61 
References ................................................................................................. 62 
 
CHAPTER THREE:  Rapid expulsion of Trichinella spiralis by tyvelose- 
specific rat IgG2a in a model of intestinal immunity........................................ 66 
  
 vii
Abstract....................................................................................................... 67 
Introduction ................................................................................................. 68 
Materials and methods................................................................................ 69 
Results........................................................................................................ 74 
Discussion .................................................................................................. 82 
Acknowledgements..................................................................................... 87 
References ................................................................................................. 89 
 
 
CHAPTER FOUR:  Parenteral infection induces intestinal immunity        
against Trichinella spiralis. ............................................................................. 90 
Abstract....................................................................................................... 91 
Introduction ................................................................................................. 91 
Materials and methods................................................................................ 93 
Results........................................................................................................ 97 
Discussion ................................................................................................ 105 
Acknowledgements................................................................................... 112 
References ............................................................................................... 113 
 
 
CHAPTER FIVE:  Summary and conclusions.................................................... 118 
References ............................................................................................... 128 
 
 
  
 viii
LIST OF FIGURES 
 
Figure 2.1:  Comparison of properties of RBL-2H3 cells with BMMC. ............ 47 
 
Figure 2.2:  Flow cytometric analysis of binding by immune complexes           
to Fc receptors on RBL-2H3 cells and rat BMMC........................................... 49 
 
Figure 2.3:  Comparison of surface expression of FcγRII and FcεRI on       
RBL-2H3 cells and BMMC.............................................................................. 52 
 
Figure 2.4:  Degranulation of RBL-2H3 cells induced by antibodies    
complexed with T.spiralis ESA. ...................................................................... 53 
 
Figure 2.5:  Degranulation responses of RBL-2H3 cells and BMMC.............. 55 
 
Figure 2.6:  Direct antigen binding to BMMC and RBL-2H3 cells. .................. 57 
 
Figure 3.1:  Intestinal mastocytosis induced by H. polygyrus infection in 
different strains of rats. ................................................................................... 75 
 
Figure 3.2:  Dose response of cross-protection and mastocytosis          
induced by infection with H. polygyrus in Lewis rats....................................... 76 
 
Figure 3.3:  Passive immunization of Lewis and AO rats with tyvelose-    
specific monoclonal rat IgG2a. ....................................................................... 78 
 
Figure 3.4:  Distribution of T. spiralis larvae in intestinal tracts of naïve         
and immunized rats. ....................................................................................... 80 
 
Figure 3.5:  Measurement of RMCP-II in sera of immunized or naïve        
Lewis rats following challenge with T. spiralis. ............................................... 81 
 
Figure 3.6:  The role of the Fc in protective immunity mediated by IgG2a. .... 83 
 
Figure 4.1:  Specificity of immunity induced by parenteral infection. .............. 98 
 
Figure 4.2:  Distribution of larvae in parenterally immunized AO and         
Lewis rats.. ................................................................................................... 100 
 
Figure 4.3:  Intestinal mastocytosis, goblet cell hyperplasia, esoinophilia,        
or peripheral blood eosinophilia in parenterally infected or naïve AO or      
Lewis rats. .................................................................................................... 101 
 
  
 ix
Figure 4.4:  Detection of serum RMCP-II during oral or parenteral         
infection and rapid expulsion. ....................................................................... 104 
 
Figure 4.5:  Antibody isotypes produced in response to infection with T. 
spiralis. ......................................................................................................... 106 
 
Figure 4.6:  Effect of C3 depletion on rapid expulsion induced by       
parenteral infection....................................................................................... 107 
 
Figure 5.1:  Model of immunity induced by parenteral immunization............ 126 
 
 1
 
 
 
CHAPTER ONE 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2
A.  Relevance of this research 
 
Prevalence of allergic diseases is increasing worldwide, most markedly 
in Western and English speaking countries (16).  In the United States, asthma 
is considered epidemic (80).  In addition to increased incidence of Th2 
mediated disease, including asthma, atopic eczema, and allergic rhinitis, there 
is increased incidence of Th1 mediated autoimmune disease, such as 
diabetes, inflammatory bowel disease, and multiple sclerosis (35, 96, 103).   
While the reasons for this are multi-factorial, it is clear that there is a direct 
correlation between reduced infection and increased allergic disease.  This 
association was first recognized by Strachan in the formulation of the hygiene 
hypothesis (108).  Emergence does not correlate well with pollution (29), but 
more with factors related to hygiene such as decreased parasite burdens and 
reduced exposure to infectious agents in early childhood (70, 117, 125).  
Infections appear to modulate the immune system, most likely through T 
regulatory cells that inhibit activation of T effector cells and limit inflammation, 
thereby preventing manifestations of allergy and autoimmunity (41, 96).   
Both allergic disease and helminth infections are characterized by Th2 
responses, but the former is the product of inappropriate immune regulation.  It 
has been observed that parasitic infections can decrease or prevent allergic 
responses.  For example, the suppressive effect of parasitic infection on atopy 
was demonstrated in persistently parasitized children in Gabon.  Children 
treated with anthelmintic showed stronger skin prick test responses to house 
dust mite antigen provocation compared to untreated children (117).  One 
hypothesis for decreased allergic sensitivity in parasitized individuals states 
that IgE binding sites on basophils and mast cells are blocked by polyclonal 
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IgE induced by parasitic infection.  However, changes in total serum IgE 
concentrations in Gabonese children were not sufficient to implicate this as the 
mechanism for increased allergic sensitivity (117).  This hypothesis was 
further refuted by in vitro studies demonstrating that polyclonal IgE from 
filarial-infected individuals does not saturate basophil Fc receptors and only 
blocks allergen-specific IgE responses at non-physiologic concentrations (82).  
Recent data support a role for T regulatory cells in allergy observed in 
persistently parasitized individuals.  
Many allergic disorders are associated with mast cell activation at 
mucosal surfaces.  Likewise, gastrointestinal nematodes induce mastocytosis 
and for some parasites, mastocytosis is necessary for parasite expulsion (66, 
126).  In addition, parasitic infection induces production of IL-10 and TGF-β, 
two canonical regulatory cytokines (123). Since humans have evolved in close 
association with parasites, it is reasonable to predict that removal of such a 
persistent stimulus to the immune system may affect immune responses to 
other antigens.  Investigations of the immune response to parasites could be 
useful for discovering methods to control immune pathologies seen in the 
absence of parasitism. 
In developed societies, the absence of parasitic infection likely 
contributes to increases in allergic and autoimmune diseases; however, in 
developing societies parasitic nematode infections remain a significant health 
problem for people and for livestock.  Of particular concern is the ability of 
parasites to become resistant to anthelmintic treatments.  This concern is 
augmented by a dearth of new anthelmintic drugs.  In 2001, the World Health 
Organization (WHO) set minimal treatment targets for reducing morbidity due 
to helminth infections in humans (5).   Likewise, the Global Alliance for the 
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Elimination of Lymphatic Filariasis (GAELF) organized a two-drug 
(albendazole and ivermectin) yearly treatment plan for 26 million people in 22 
endemic countries (5).  As these mass treatment programs become more 
frequent, the emergence of multi-drug resistance in human parasites may rival 
multi-drug resistance documented in livestock populations (46, 61).   
There are fewer case reports of anthelmintic drug resistance in 
parasites of humans than in those of livestock.  However, resistance has been 
documented for treatment with praziquantel of Schistosoma haematobium (8), 
ivermectin of Onchocerca volvulus (43), and pyrantel of Ancylostoma 
duodenale (99).  Treatment programs for gastrointestinal parasites of livestock 
have resulted in multi-drug resistance on a global scale, particularly in small 
ruminant populations (46).  In goat populations of the southern United States, 
gastrointestinal nematodes are resistant to all currently available anthelmintics 
(84).  Ivermectin resistance presents ever increasing treatment complications 
not only for Haemonchus contortus in small ruminants but also for Onchocerca 
volvulus in humans (43).  In light of these trends, vaccination against parasitic 
infection has renewed relevance for both human and livestock populations.   
The goal of vaccine development against parasites has been 
encumbered by the complexity of immune responses to parasitic infection 
compounded by mechanistic differences among the large number of host-
parasite interactions.  While there certainly is no single path to solving this 
complex issue, our understanding of immunity to parasites has advanced 
using model systems such as vaccination against H. contortus in sheep (98).  
Vaccination against Onchocera ochengi in cattle induced protective immunity 
(110), and this model might be beneficial for vaccine development against 
filarial nematodes of humans.  Another productive laboratory model for 
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studying the immune response to parasitic nematode infection is Trichinella 
spiralis in rats.  
 
B.  Life-cycle of T. spiralis 
 
 T. spiralis is a useful laboratory model of nematode infection for several 
reasons.  First, T. spiralis is unusual among parasitic nematodes in that it 
completes its life-cycle within one host.  Thus the parasite is easily propagated 
and maintained within the laboratory environment.  Second, during the course 
of the T. spiralis life cycle, the first-stage larvae resides in the mucosal 
environment of the gastrointestinal tract as well as within the systemic 
environment of the skeletal muscle.  This provides an opportunity to test 
mucosal and systemic immunity generated against the same life stage.   
 Infectious first-stage larvae (L1) are transmitted to the host by ingestion 
of raw meat from an infected animal.  This initiates the enteral phase of 
infection.  Digestion by stomach pepsin releases larvae from muscle tissue.  
L1 immediately enter the epithelium of the proximal small intestine.  Within 
thirty hours the larvae molt four times to reach the adult stage.  Mating occurs 
within the intestinal epithelium.  Female worms are viviparous and release live 
newborn larvae (NBL) which migrate through the portal circulation and 
vasculature.  Migrating larvae pass through most organs of the body, including 
the heart, liver, and lungs.  NBL have a predilection for skeletal muscle where 
they begin establishment of their niche within a structure called the Nurse cell.  
For rodents, Nurse cell development is concurrent with expulsion of adult 
worms from the intestine, between ten and twenty days after oral infection.  
Thus ends the enteral phase of infection and begins the parenteral or systemic 
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phase of infection which is a chronic, persistent infection eliciting a potent 
immune response.  After approximately twenty days of development in the 
Nurse cell, the larvae become infectious, and the life-cycle can be repeated in 
a new host.  The Nurse cell can support viable larvae for as long as 30 years.  
It is important to note the distinction between the enteral and parenteral 
phases of T. spiralis infection.  In some of our studies, we manipulated the life-
cycle by establishing muscle infections without enteral infection by injecting 
rats intravenously with NBL.  
 
C.  The immune response to T. spiralis  
 
1.  Rapid expulsion of T. spiralis 
Rats naturally infected with T. spiralis are completely immune to 
secondary infections.  This strong immune response has been referred to as 
rapid expulsion.  Rats respond to a challenge infection with Trichinella by 
expelling 99% of intestinal larvae within a few hours (23, 33, 71, 76).  This 
protective immunity lasts seven weeks or longer in rats (6).  Multiple rat strains 
display rapid expulsion when challenged after natural infection (18).  Because 
this immunity is exclusively observed in rats (6), mechanistic studies have 
been hindered due to the lack of transgenic and knock-out animals as well as 
reagents that are more readily obtainable in mice.  Nevertheless, studies of 
rapid expulsion in the rat provide insights to immunity against parasites.  
Historically, investigations have attempted to identify a single mediator 
of rapid expulsion, but this has been challenging because of the complexity of 
the inflammatory response to oral infection that is induced prior to expulsion.  
In adult rats, it was determined that rapid expulsion requires two discrete 
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stimuli (20): both intestinal inflammation and antibody.   In addition, rapid 
expulsion is specific for first-stage larvae (L1) (22) and can be recreated by 
passive immunization with parasite-specific IgE or certain IgG isotypes.  
However, passive immunity occurs only in recipients that have previously 
experienced an oral infection with a heterologous nematode, such as 
Heligmosomoides polygyrus or Nippostrongylus brasiliensis (20, 51).  Since 
antibody alone is not protective, it has been speculated that antibodies might 
be interacting with some cellular component of the immune system that is 
expanded or induced by intestinal infection.  Prominent cellular changes in the 
intestine due to infection include mastocytosis, eosinophilia, and goblet cell 
hyperplasia (6, 60).  The first two cell types bear Fc receptors (FcR), and it is 
possible that immune complexes might activate these cells in the inflamed 
intestine.   
While a direct role for mast cells in rapid expulsion has not been 
demonstrated, intestinal mastocytosis and mast cell activation occurs during 
expulsion of adult worms from the intestine in a primary infection (124), and 
mast cells are activated during expulsion of a challenge infection (83).  
Additionally, mediators released from mast cells during expulsion result in 
dramatic changes in the intestinal environment which may be detrimental to 
parasite establishment.  Rat mast cell protease-II (RMCP-II) (105, 106), 
prostaglandins (128), serotonin (54, 75), leukotrienes (83), histamine (54, 
128), and cytokines (54) affect intestinal secretion (34), permeability (25, 102), 
and smooth muscle contraction (119).  Any one or more of these mechanisms 
could contribute to nematode expulsion.  Since nematode infection provokes 
such complex intestinal changes, a single mechanistic explanation for rapid 
expulsion remains difficult to elucidate.  Furthermore, infection also induces 
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CD4+ T cell activation, CD8+ T cell activation, B cell activation, and specific 
antibody production.  Clearly, the immunity referred to as rapid expulsion is a 
complex orchestration of events leading to parasite elimination from the 
intestine.  Any of these factors could mediate rapid expulsion or cooperate to 
produce it.  The role of each mediator in primary and secondary infections will 
be discussed individually. 
 
2.  The role of mast cells in immunity to T. spiralis 
Mast cells play a role in primary expulsion of T. spiralis from mice and 
rats.  T. spiralis induces intestinal mastocytosis, and mast cell activation 
coincides with expulsion of adult worms from the intestine of both mice and 
rats (6).  Intestinal mastocytosis is T-cell and antigen dependent (94, 95, 100).  
Expulsion of adult worms is prolonged in athymic nude rats (120), and mast 
cell deficient Wv/Wv mice infected with T. spiralis are slower to expel adult 
worms than mast cell-replet littermates (50).  In mice, bone marrow grafting of 
mast cells resulted in restoration of intestinal mastocytosis and accelerated 
expulsion (50, 90).  Stem cell factor (SCF) and interleukin-3 (IL-3) are 
essential for development of intestinal mastocytosis to nematode infections.  
Expulsion of adult T. spiralis is impaired in mice deficient in either IL-3 or SCF 
or both (69).  Neutralization of SCF by injecting mice with anti-SCF or anti-
SCF receptor antibodies impaired intestinal mastocytosis and adult worm 
expulsion of T. spiralis (39, 47).  Conversely, supplementation of mice with IL-
3 resulted in an earlier induction of intestinal mastocytosis and enhanced 
worm expulsion of T. spiralis (68).  Additionally it has been observed that 
interleukin-9 (IL-9) transgenic mice have abnormally large populations of 
intestinal mast cells and displayed enhanced expulsion of adult T. spiralis 
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worms (45).  This enhanced expulsion can be abrogated by treatment with 
antibody against the SCF receptor, c-kit (45).  It has been observed that 
mouse strains demonstrate different kinetics for T. spiralis adult worm 
expulsion, and these differences correlate with mastocytosis within the 
intestine (28).  Mast cell activation occurs during adult worm expulsion, as 
demonstrated by detection of mouse mast cell protease-I (MMCP-I) in sera 
(57).  Furthermore, T. spiralis expulsion is delayed in mice lacking MMCP-I 
(66).  
Intestinal mastocytosis occurs during enteral infection of rats with T. 
spiralis (75).  Mast cell activation is coincident with rapid expulsion of T. 
spiralis from the rat intestine (20, 83).  Although pharmacologic inhibition of 
many mast cell mediators released during expulsion failed to inhibit rapid 
expulsion (24), inhibition of serotonin by the serotonin receptor antagonists, 
ketanserin and MDL-722222, significantly inhibited rapid expulsion (127).  
These findings are discussed in more detail in section 3 below.   
Because rapid expulsion is a phenomenon unique to the rat, studies 
implicating the mast cells in rapid expulsion have been limited due to the 
shortage of mutant, knock-out, or transgenic animals.  A spontaneous mutant 
rat strain, Ws/Ws, has been described that is mast cell deficient (111).  There 
are very few reports describing immunity in this strain, largely due to their poor 
reproductive performance and overall health status.  
The role of the mast cell in immunity to parasitic nematodes has been 
demonstrated for Strongyloides venezuelensis.  Similar to T. spiralis infection, 
Wv/Wv mast cell deficient mice infected with S. venezuelensis are slower to 
expel adult worms; and bone-marrow grafting of mast cells restores intestinal 
mastocytosis and accelerates expulsion (63).  In contrast, immunity to some 
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parasitic nematodes does not require mast cells.  Expulsion of 
Nippostrongylus brasiliensis is not dependent on intestinal mastocytosis (1, 
112).  Thus the influence of mast cells in immunity to parasitic nematodes 
varies among species. 
 
3.  The role of increased intestinal permeability and secretion in immunity to T. 
spiralis 
Mast cells release many pro-inflammatory mediators that cause 
dramatic physiologic changes in the intestinal environment.  Experiments have 
been designed to remove or replace these mediators in order to identify which 
one might be responsible for worm expulsion.  Increased intestinal 
permeability and secretion occurs during expulsion of primary infections with 
T. spiralis and is thought to contribute to parasite elimination from the 
intestine.  Treatment of IL-9 transgenic mice with antibody against the SCF 
receptor, c-kit, decreased intestinal permeability and delayed expulsion of T. 
spiralis adult worms (77).  This suggests that mast cell induced intestinal 
permeability contributes to worm expulsion. 
Intestinal permeability is increased during secondary infection with T. 
spiralis, and some studies implicated increased intestinal secretion and 
permeability in parasite expulsion.  MMCP-I deficient mice displayed reduced 
intestinal permeability and delayed expulsion of a challenge infection (77).  
Increased epithelial permeability via a paracellular route has been 
demonstrated during a challenge infection with N. brasiliensis in the rat and is 
due to RMCP-II (106).  RMCP-II alters the distribution of tight junction proteins, 
ZO-1 and occludin, in the intestinal epithelium leading to increased 
permeability (104).  Since RMCP-II is released during a challenge infection 
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with T. spiralis in the rat (83), these physiologic changes in the intestine are 
presumably present during expulsion.  Additional mast cell mediators, such as 
histamine, 5-hydroxy-tryptamine (5-HT), and prostaglandin E2 (PGE2) all 
contribute to anaphylaxis-induced ion transport changes in the small intestines 
of rats immunized against T. spiralis (34).  These changes in intestinal Cl- 
secretion are biphasic, comprised of a phase I induced by 5-HT and histamine 
and a phase II induced by PGE2  (34) and mediated in part by cAMP (53, 101).  
This biphasic pattern of epithelial Cl- secretion is observed in the jejunum from 
rats infected with T. spiralis and then challenged (51).  Furthermore, 
investigations showed that rats passively immunized with immune serum 
exhibit only the late phase of secretion and were not protected, implicating the 
early response as essential for protection.  Furthermore, greater numbers of 
mast cells or altered activation of mast cells in the mucosa appear necessary 
to generate a full anaphylactic response in the epithelium (51).  Inhibition of 
histamine and prostaglandins does not affect worm expulsion (24, 127); 
however, inhibition of 5-HT does impede worm expulsion during challenge 
infection.  It was demonstrated that the effects of 5-HT on worm expulsion was 
independent of Cl- secretion, and that intestinal secretion was coincidental with 
but not contributory to expulsion (127).  Other effects of 5-HT on the intestine 
include enhanced mucus output, increased motility, and altered mesenteric 
blood flow (91); and any of these might impact worm establishment within the 
intestine. 
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4.  The role of muscle hypertrophy and hypercontractility in immunity to T. 
spiralis 
A primary infection with T. spiralis cause changes in rat intestinal 
myoelectric activity resulting in abnormal gut motility that possibly contributes 
to parasite expulsion (93).  In rats infected with T. spiralis, mast cell numbers 
were increased in the longitudinal muscle of the jejunum.  Exposure to T. 
spiralis antigen induced mast cell degranulation causing muscle contraction 
that could be inhibited with either the mast cell stabilizer, doxantrazole, or with 
5-HT antagonist, cyproheptadine (119) (75).  T. spiralis infection in both rats 
and mice causes persistent hyperplasia and hypertrophy of smooth muscle in 
the small intestine (26, 113, 122).  These smooth muscle changes alter 
intestinal motility and may contribute to parasite expulsion.  Because 
nematode infections induce significant mastocytosis and 5-HT release, both of 
which contribute to parasite expulsion and to increased muscle contractility, it 
is speculated that mast cells might be mediating smooth muscle changes via 
5-HT.  However, experiments using mast cell deficient mice (Wv/Wv) 
demonstrated that this was not the case (114).  While T. spiralis infected 
Wv/Wv mice display delayed expulsion that was partially restored by mast cell 
reconstitution, the disruptions in smooth muscle contraction are not restored 
(114).  Wv/Wv mice also lack a population of c-kit dependent cells, interstitial 
cells of Cajal (ICC), which regulate the myoelectrical slow wave activity that 
controls intestinal motility (114).  Thus, these cells promote smooth muscle 
contractility and likely contribute to parasite expulsion.   
Additional experiments have revealed the T-cell dependency of smooth 
muscle hypertrophy and hypercontractility in response to T. spiralis infection in 
mice and rats (118), (115).  Studies, utilizing IL-4 deficient and signal 
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transducer and activator of transcription factor 6 (STAT-6) deficient mice, 
demonstrated that acute infection with T. spiralis leads to increases in IL-4 and 
IL-13 via STAT-6 that mediate smooth muscle hypercontractility and parasite 
expulsion (3, 64).  Smooth muscle hypertrophy and hypercontractility persists 
for six weeks after intestinal inflammation has abated.  This persistence is due 
to acute changes in the smooth muscle induced by IL-4, IL-13, and TGF-β and 
is maintained by TGF-β.  Induction of COX-2 by TGF-β leads to PGE2 
production at the level of the muscle cell (4).  Rapid expulsion is demonstrated 
by rats challenged several months after primary infection.  It is not clear that 
smooth muscle changes induced by primary infection in the rat are sustained 
in the longer term.  
 
5.  The role of eosinophils in immunity to T. spiralis 
Eosinophils kill T. spiralis NBL when incubated in the presence of 
immune serum (62).  It has been shown that mice treated with anti-eosinophil 
serum acquire increased muscle larvae burdens (48), suggesting that 
eosinophils participate in defense against migrating NBL.  Furthermore, CCR3 
deficient mice display reduced eosinophil recruitment to muscle tissue and a 
corresponding reduction in larvae toxicity (49).  In contrast to these studies, 
transgenic mice overexpressing IL-5 with marked eosinophilia did not display 
increased larval killing (56). 
In response to a primary infection with T. spiralis, rats mount a 
peripherial blood, intestinal, and bone-marrow eosinophilia (60) (15, 38, 107).    
However, interleukin-5 deficient mice infected with T. spiralis expel adult 
worms with kinetics similar to infected heterozygous controls, suggesting that 
eosinophilia does not play a significant role in expulsion of adult worms from 
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the intestine.  Additionally, depletion of eosinophils by anit-IL-5 antibody 
treatment of mice infected with T. spiralis demonstrated no effect on the 
course of primary infection (55).  Transgenic mice overexpressing IL-5 also did 
not expel T. spiralis any faster than control mice (56).  Therefore, eosinophils 
more likely participate in protection against T. spiralis NBL than against adult 
worms.  
A role for eosinophils in immunity to secondary infections was 
demonstrated in IL-5 deficient mice challenged with T. spiralis (116).  These 
mice have significantly larger worm burdens and display slower expulsion 
kinetics.  Adoptive transfer of thoracic duct T cells (OX8-,OX22-) from T. 
spiralis-infected rats induced intestinal eosinophilia and provided moderate 
protection against challenge (121).  More definitive studies addressing the role 
of eosinophils in rapid expulsion of T. spiralis from the rat are lacking.  
Peripherial eosinophilia is associated with the expulsion of a challenge 
infection of S. venezuelensis in rats (14); however, in N. brasiliensis infected 
rats, an intense peripherial eosinophilia is mounted in the absence of intestinal 
eosinophilia (109).  The in vivo function of eosinophils in protection against 
parasites remains controversial (17, 79).   
 
6.  The role of goblet cell hyperplasia and mucus entrapment in immunity to T. 
spiralis 
Intestinal goblet cell hyperplasia is a characteristic response to 
nematode infection in the mice and rats (6).  In rats, goblet cell hyperplasia 
and alteration in goblet cell mucins seem to play a role in immunity to N. 
brasiliensis (59, 81).  Quantitative as well as qualitative changes in mucus, 
such as changes from neutral to acid mucins (67) and alteration in the terminal 
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sugars of mucins (59), enhance immunity to nematodes. Furthermore, 
RELMβ, a protein produced by goblet cells, is upregulated in mice infected 
with T. spiralis (65).  While RELMβ binds to the chemosensory apparatus and 
inhibits chemotaxic function of Trichuris muris in vitro (13), it does not inhibit T. 
spiralis epithelial penetration and migration in vitro (unpublished data).  Mucus 
entrapment alone, or in coordination with antibody (31) occurs during rapid 
expulsion of T. spiralis in the rat.  In suckling rats, IgG1 and IgG2c promote 
entrapment of larvae in mucus (30).  Mucus entrapment of larvae did not occur 
in weaned rats passively immunized with IgG2c nor were these rats protected 
(92); however H. polygyrus infected adult rats that were passively immunized 
with IgG1 and challenged did display mucus entrapment (20).  Rapid 
expulsion does occur without mucus entrapment in rats that are immunized 
with an abbreviated oral infection (19).   Furthermore, it has been observed 
that mucus entrapment is reversible and thus may not be essential for rapid 
expulsion of T. spiralis in the rat (92). 
 
7.  The role of antibody in immunity to T. spiralis 
Rodents infected with T. spiralis mount a strong antibody response to 
muscle larvae.  The isotypes that are prominent in the response are those 
influenced by Th2 cytokine activation.  In general, mice respond to primary 
infection by producing IgE and IgG1, some IgM and IgA, and little IgG2b and 
IgG3 (7).  Re-infection stimulates both IgE and IgG1 (85).  In rats nine weeks 
post-infection, Th2 driven isotypes (IgG1 and IgG2a) are dominant, followed 
by IgG2c with little IgG2b (12).  While there are conflicting data concerning the 
role for antibody in adult worm expulsion, there is substantial evidence that 
antibody is pivotal for rapid expulsion of a challenge infection (9, 12, 20).  Rat 
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pups suckling a T. spiralis infected foster dam demonstrate rapid expulsion of 
T. spiralis.  Immunity is conferred by parasite specific antibodies in the milk or 
by passive transfer of immune serum (10, 11).  These antibodies are specific 
for a highly immunogenic sugar, tyvelose that is produced by infectious first-
stage larvae (40).  In addition, anti-tyvelose monoclonal antibodies IgG1 and 
IgG2c are protective in neonatal rats but IgG2a and IgG2b are not (9, 12, 32).  
While these data provide strong evidence for the role of antibody in suckling 
rats, the situation in weaned and adult rats differs.   
Passive transfer of monoclonal antibodies or immune serum from T. 
spiralis infected rats fails to promote rapid expulsion in weaned rats (92).  
However, antibodies are protective when rats have been primed by an 
intestinal infection with an antigenically unrelated nematode such as H. 
polygyrus (20) or N. brasiliensis (53).  IgE, IgG1, IgG2a, and IgG2c are all 
protective (20).  Alternatively, rapid expulsion is demonstrated by rats infected 
with H. polygyrus (21), or T. spiralis (34) and immunized parenterally with T. 
spiralis larval antigens.   
Whether or not antibody cooperates with complement to cause rapid 
expulsion has not been determined.  All rat IgG isotypes can fix complement; 
however, IgG2a and IgG2b activate complement most efficiently.  Bell et al. 
showed that depletion of complement with cobra venom factor inhibited rapid 
expulsion; however, the result was not repeatable (24).  Since antibody alone 
cannot cause rapid expulsion, it has been thought that antibodies might be 
interacting with FcR-bearing immune cells, with complement, or with intestinal 
mucus to effect rapid expulsion.  
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8.  The role of lymphocytes in rapid expulsion of T. spiralis 
A role for lymphocytes in expulsion has not been thoroughly 
investigated.  Furthermore, it is difficult to interpret the effects of 
immunosuppression in rats, because T-cell suppression decreases intestinal 
mastocytosis, eosinophilia, and antibody responses of which may contribute to 
expulsion (52).  Transfer of thoracic duct lymphocytes, both B and T cell 
fractions, conferred protection to naïve rats (36, 37, 121); however, this 
immunity was not rapid expulsion.  Evidence that lymphocytes contribute to 
rapid expulsion was demonstrated by adoptive transfer of thoracic duct OX38+, 
OX8-, OX22- T helper cells from T. spiralis infected rats to naïve rats (2).  
When these cells were transferred together with serum antibody protection 
was conferred on the recipients; however, protection was not optimal in this 
system, as only 40-60% reduction of the challenge dose was expelled.  The 
cells transferred were collected from the thoracic duct three days after an oral 
infection.  Therefore these cells are T-cells which were activated in the 
intestine and not T-cells which are activated later in the course of T. spiralis 
infection by muscle larvae.  For complete worm rejection, it is likely that the 
potent antigenic stimulation provided by T.spiralis muscle larvae is essential.  
This is one explanation for the weak protection demonstrated in the thoracic 
duct cell transfer model.  Thoracic duct T cells were also purified into two 
separate T-cell populations, OX22+ and OX22- cells, and transferred to rats.  
Interestingly, OX22+ cells induced intestinal mastocytosis but were not 
protective, while OX22- cells induced eosinophilia and were protective (121).  
A pivotal role in protection for eosinophils was not demonstrated, and it is not 
clear that the inflammatory changes observed were causal in protection.  This 
adoptive transfer model does not reproduce a level of protection similar to 
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rapid expulsion.  We speculate that T lymphocytes activated in the skeletal 
muscle are critical in promoting rapid expulsion. 
 
D.  The mucosal phenotype of rat bone marrow-derived mast cells 
(BMMC) and RBL-2H3 cells 
 
We chose to use rat bone marrow-derived mast cells (BMMC) and 
RBL-2H3 cells to investigate whether parasite specific immune complexes 
could activate mast cells via Fc receptors.  RBL-2H3 cells are a clonal cell line 
derived from a rat basophilic leukemia tumor.  This cell line is the best 
characterized clonal model for in vitro studies of mucosal mast cells.  Rat 
BMMC grown in culture with IL-3 and SCF display a superior homogenous 
mucosal phenotype when compared to other primary mast cell models such as 
peritoneal mast cells or mouse BMMC (73).  Comparative studies of rat BMMC 
with its mucosal in vivo counterpart have demonstrated that these cells are 
biochemically and functionally similar (73).  BMMC granules stain uniformly 
blue with Alcian blue, a dye that binds sulphated acid mucopolysaccharides 
and differentiates mucosal from connective tissue mast cell phenotypes in the 
rat (42).  In addition, BMMC granules contain RMCP-II that is unique to 
mucosal mast cells (58).  Cross-linking of surface bound IgE stimulates the 
release of RMCP-II, β-hexosaminidase, and leukotriene C4 and TNF-α from 
BMMC (72, 73).  The influence of IgG and immune complexes formed by IgG 
on BMMC has not been characterized previously.  Mast cells are implicated in 
immunity to parasitic nematode infection, yet the mechanism for how they are 
activated to effect worm expulsion has remained elusive.  One of the aims of 
this research was to investigate binding and activation of BMMC by IgG 
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containing immune complexes.  We compared BMMC with the RBL-2H3 cell 
line, a thoroughly characterized model of the rat mucosal mast cell. 
 
E.  Trichinella antigens and IgG immune complexes 
 
We utilized for our studies rat monoclonal IgGs (IgG1, IgG2a, IgG2b, 
and IgG2c) and polyclonal IgE that are specific for the immunodominant N-
linked glycans produced exclusively by first-stage T. spiralis larvae.  These 
antibodies bind to tyvelose, a 3, 6-dideoxy-D-arabinohexose that is terminally 
linked to tri- and tetra-antennary N-linked glycans (40).  The glycans modify 
several glycoproteins synthesized by stichocytes and secreted by larvae as 
they enter the intestine.  Excretory-secretory antigens are rich in tyvelose 
bearing glycoproteins.  In addition, tyvelose modifies glycoproteins on the 
surface of larvae.  Tyvelose is highly immunogenic and is bound by antibodies 
that mediate rapid expulsion in suckling rats.  Interaction between T. spiralis 
antigens and antibodies are thought to inhibit the parasite within the intestinal 
environment by promoting mucus entrapment (30).  Invasion of the intestinal 
epithelium by T. spiralis can be studied in vitro (74).  Using this system, it was 
demonstrated that immune complexes form large aggregates and create cap-
like structures on the anterior end of the parasite (78).  This forms a physical 
barrier which interferes with sensory reception and impedes epithelial 
invasion.  In addition, antibodies to tyvelose can encumber or immoblize 
larvae as they migrate through epithelial cells.  Because of the structural 
nature of these immune complexes, we hypothesized that they would 
efficiently aggregate FcRs and cause activation of mast cells.  
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F.  Fc receptors    
 
Mast cell activation by Fc receptor engagement is regulated by 
cytoplasmic domains found in the receptor itself (α-chain) or in associated co-
receptors (β and γ chains).  Activating motifs (ITAMs) are inhibited by 
aggregation with receptors bearing inhibitory motifs (ITIMs) (97).  The outcome 
of receptor engagement depends upon the properties of the specific receptors 
engaged and also on the quantity of receptor aggregation.  High affinity Fc 
receptors bind to monomeric immunoglobulin or to immune complexes.  Low 
affinity Fc receptors bind only complexes. 
RBL-2H3 cells express the high affinity IgE receptor (FcεRI) and the low 
affinity, inhibitory IgG receptor (FcγRII) (27).  While mRNA encoding FcγRIII is 
detectable in RBL-2H3 cells (44), surface expression is not evident (our 
results).  There are at least 8 different isoforms (A-H) of this FcR identified in 
the rat, suggesting greater biologic FcγR plasticity in this species (44).  Fc 
receptor expression in rat BMMC has not been described.    
Human mast cells treated with IFN-γ express a high affinity Fc gamma 
receptor (FcγRI) that induces mast cell degranulation upon aggregation with 
IgG containing immune complexes (89).  Aggregation of either FcεRI or FcγRI 
releases 22 different cytokines or chemokines (88).  Interestingly, FcγRI 
aggregation released greater quantities of some of these inflammatory 
mediators when compared to FcεRI (88), demonstrating the potential of mast 
cells to be differentially activated by FcRs.  It has not been determined 
whether rat mast cells can express FcγRI.   
A novel FcR, FcγRIV, has recently been discovered on mouse myeloid 
cells (86).  This receptor demonstrates distinct IgG isotype specificity for 
 21
IgG2a and IgG2b, thus providing another level of regulation inducible by IgG 
immune complexes.  This FcR type has not yet been described in the rat.  
The role of Fc receptor ratios (activating versus inhibitory) in modulating 
cellular responses that in turn influence immunity is only beginning to be 
appreciated (87).  IgG immune complex binding and activation of rat mucosal 
mast cells via a Fc gamma receptor has not been documented.  Because of 
the potential diversity of FcR on rat mast cells and the different antibody 
isotypes generated in parasitic infection, I postulated that immune complex 
interactions with FcR on mast cells are an important mechanism of regulation 
in parasitic infection.   
 
G.  Objectives of study 
  
Rapid expulsion of T. spiralis from the rat occurs in conjunction with 
mast cell activation, and pharmacologic inhibition of 5-HT released from mast 
cells impairs expulsion (127).  In addition rapid expulsion is antibody 
dependent.  Thus, we desired to investigate a direct role for immune complex 
activation of the mast cell via FcR.  We initially cultured mucosal mast cells 
from rat bone marrow in parallel with the mucosal mast cell line RBL-2H3 in 
order to pursue in vitro studies of immune complex binding and activation of 
mast cells.  Because IgG2a binds to and triggers mast cell degranulation in 
vitro, we desired to further analyze the mechanism of action for this isotype in 
rapid expulsion in vivo.  Our goals were to determine whether IgG2a-mediated 
protection was dependent on the Fc portion of the antibody or on complement.  
We diversified our approach to the question by using a parenteral 
immunization model to further our investigations on rapid expulsion.  
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Parenteral immunization is a very robust model of rapid expulsion and 
eliminates many of the confounding effects of intestinal inflammation induced 
by primary oral infection.   
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Abstract 
Our aim is to test the role of mucosal mast cells in expulsion of 
Trichinella spiralis from the intestinal epithelium during a challenge infection.  
As part of this evaluation, we cultured mast cells from the bone marrow of rats 
for in vitro studies and compared them in a variety of assays with the model 
mucosal mast cell line, RBL-2H3.  Rat bone marrow-derived mast cells 
(BMMC) displayed a homogenous mucosal phenotype as determined by 
uptake of Alcian blue and detection of rat mast cell protease-II (RMCP-II).  
BMMC were labeled with the mast cell specific ganglioside GD1b antibody.  In 
comparison, RBL-2H3 were less granular, produced less β-hexosaminidase, 
and contained little to no RMCP-II.  We determined by flow cytometric analysis 
that immune-complexes formed with parasite glycoproteins and tyvelose-
specific rat IgG1, IgG2a, and IgG2b but not IgG2c bound to Fc receptors on 
RBL-2H3 and BMMC.  Blocking experiments revealed that IgG1 and IgG2a 
complexes bound to the high affinity IgE receptor (FcεRI) and a low affinity IgG 
receptor (FcγRII).  IgE bound FcεRI and induced degranulation.  We found 
that IgG2a but not IgG1 complexes induced degranulation of RBL-2H3; 
however, neither isotype induced significant degranulation of BMMC.  IgG2b 
bound only FcγRIIb and did not induce degranulation.  These results were 
confirmed with the highly characterized anti-DNP IgE and IgG2a, each 
complexed with DNP-BSA.  BMMC had an increased expression of FcγRII and 
reduced expression of FcεRI compared to RBL-2H3 cells.  Poor stimulation of 
BMMC by IgG complexes is postulated to be due to inhibition by FcγRII 
combined with a weak FcεRI signal.  Our results suggest that rat mucosal 
mast cells are refractory to activation by IgG.   
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Introduction 
Infection of rodents with the parasitic nematode Trichinella spiralis 
causes pronounced intestinal mastocytosis.  Systemic release of mast cell 
mediators is coincident with parasite expulsion during primary and secondary 
infections (25, 34).  Transgenic mice lacking the gene for mucosal mast cell 
specific, mouse mast cell protease-I (MMCP-I) demonstrate delayed expulsion 
of a primary infection with T. spiralis (19).  In rats, mucosal mast cell specific 
rat mast cell protease-II (RMCP-II) is released during adult worm expulsion of 
T. spiralis (34) and during expulsion of secondary infections (25).  Immunity to 
a challenge infection with T. spiralis has been characterized as intestinal 
anaphylaxis due to the rapid kinetics of worm expulsion concurrent with mast 
cell activation (17).  This protective immunity, called rapid expulsion, occurs 
only in the rat and eliminates 99% of first-stage larvae from the intestine within 
hours (1).  Rapid expulsion is antibody dependent but requires an unidentified 
cellular component (6).  IgE as well as IgG isotypes (IgG1, IgG2a, and IgG2c) 
all confer protection (6).  We hypothesized that these antibodies might form 
immune complexes which interact with Fc receptors on immune cells.  Various 
mast cell mediators are elevated in serum and tissues during parasite 
expulsion; however, a role for antibodies in mast cell activation has not been 
documented.   
We chose to use rat bone marrow-derived mast cells (BMMC) to 
investigate whether parasite specific immune complexes could activate mast 
cells via Fc receptors.  Rat BMMC grown in culture with IL-3 and SCF display 
a superior homogenous mucosal phenotype when compared to other mast cell 
models such as RBL-2H3, peritoneal mast cells, or mouse BMMC (22).  
Comparative studies of rat BMMC with its mucosal in vivo counterpart have 
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demonstrated that these cells are biochemically and functionally similar (22).  
BMMC granules stain uniformly blue with Alcian blue, a dye that binds 
sulphated acid mucopolysaccharides and differentiates mucosal and 
connective tissue mast cell phenotypes in the rat (13).  In addition, BMMC 
granules contain the mucosa-specific mast cell protease, RMCP-II (22).   
Antibodies activate mast cells by binding and aggregating Fc receptors 
(FcR) on the cell surface.  Rat mast cells transcribe FcεRI and FcγRII.  These 
receptors are expressed on the surface of RBL-2H3 cells (9).  FcεRI is the 
high affinity IgE receptor that triggers mast cell degranulation when 
aggregated with either IgE or IgG2a and antigen (7).  FcγRIIb is a low affinity 
IgG receptor that, when aggregated with FcεRI, impedes mast cell 
degranulation (11).  Activating FcγRII have been identified on mouse mast 
cells but not on rat mast cells (8).  FcγRIII is a low affinity IgG receptor that 
activates mouse mast cells and induces degranulation (33).  Transcripts of 
FcγRIII have been demonstrated in RBL-2H3 cells (14), but surface 
expression and function on rat mast cells has not been described.  There are 
at least 8 different FcγRIII isoforms (A-H) identified in the rat, suggesting that 
greater Fc receptor plasticity occurs in this species (14).  The significance of 
Fc receptor ratios (activating versus inhibitory) in modulating cellular 
responses is only beginning to be appreciated (27).  FcγR-mediated activation 
of rat mucosal mast cells has not been documented.   
In this report, we describe results of experiments performed with RBL-
2H3 cells and BMMC.  We confirmed that BMMC are mucosal in phenotype 
and are more typical of mucosal mast cells than RBL-2H3 cells. The cells were 
compared for binding and activation by immune complexes, and important 
differences were found, suggesting that rat mucosal mast cells may be 
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refractory to activation by IgG due to a low activating to inhibitory (A/I) FcR 
ratio (27).    
 
Materials and Methods 
 
Rats 
Female Lewis strain rats (8 to 12 weeks old) were bred and maintained 
in the James A. Baker Institute for Animal Health vivarium.  All rodents were 
housed in accordance with the guidelines of the American Association for 
Accreditation of Laboratory Animal Care.  
 
Immunoglobulins  
T. spiralis-specific monoclonal rat antibodies of four isotypes (IgG1, 
IgG2a, IgG2b, and IgG2c; clones 9D4, 18H1, 10G11, and 9E6) were 
previously characterized (2).  Ascites fluid containing these monoclonal 
antibodies was purchased from Harlan (Indianapolis, IN), and heat inactivated 
at 56°C for 30 minutes before antibody precipitation with 40% saturated 
(NH4)2SO4 as described previously (10).  Monoclonal mouse anti-DNP IgE 
was purified as described (30), and rat anti-DNP IgG2a was purchased 
(American Research Products, Inc.; Belmont, MA).  For preparation of 
polyclonal IgE, rats were infected orally with 2,000 T. spiralis first-stage larvae 
(L1) and re-infected 30 days later with the same dose. Rats were bled by 
cardiac puncture under isoflurane anesthesia 1 week after the second 
infection.  Sera were stored at -80°C until purified by affinity chromatography 
using mouse anti-rat IgE  antibodies (A2 and B5) as described by Bell et al.  
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(6).  Antibodies were dialyzed against 0.85% normal saline and stored at  
-20°C.   
 
Antigens 
T. spiralis first-stage larvae (L1) were recovered from muscles of 
irradiated AO rats by digestion with 1% pepsin in acidified water (Crumm 
1977).  Rats had been infected at least 28 days prior to collection of larvae.   
Excretory-secretory antigen (ESA) was obtained from overnight cultures of L1 
as described previously (2).  Crude antigen (cAg) from L1 was prepared from 
whole worm homogenate as described (3), except that detergent was omitted 
from the protocol.  BSA was conjugated with an average of 15 DNP groups 
(DNP-BSA, multivalent antigen) as described (30), dialyzed against PBS, and 
stored at 4°C.  ESA was dialyzed and cAg was prepared in Dulbecco’s PBS 
(DPBS) and stored at -20°C. 
 
Cell culture 
All cell culture materials were purchased from Gibco (Grand Island, 
NY), unless otherwise noted.  Monolayer cultures of RBL-2H3 cells (5) were 
maintained in minimum essential medium (MEM) supplemented with 20% fetal 
bovine serum (Atlanta Biologicals, Inc.; Lawrenceville, GA) and 50 µg/mL 
gentamicin sulfate.  Cells were grown at 37°C in 5% CO2, and passaged by 
trypsinization weekly.  For experiments, cells were collected 3-5 days after 
passage.  BMMC were isolated and propagated using a protocol modified from 
Haig et al. (16).  Briefly, Lewis rats were euthanized by CO2 inhalation and 
cervical dislocation.  Femur bones were dissected, and bone marrow flushed 
with sterile Hank’s balanced salt solution (HBSS).  Cells were washed five 
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times in HBSS then resuspended at 0.33-0.5 X 106 cells/mL, and cultured in 
Dulbecco’s modification of Eagle’s medium (DMEM) supplemented with 20% 
horse serum, 1 mM Hepes buffer, 4 mM L-glutamine, 100 U/mL penicillin, 100 
µg/mL streptomycin, 50 µg/mL gentamicin, 100 ng/mL recombinant rat 
interleukin-3 (IL-3), and 50 ng/mL recombinant rat stem cell factor (SCF) 
(Peprotech; Rockyhill, NJ).  Cells were maintained at 37°C in 5% CO2, and 
resuspended (without trypsin) for passage every 3-5 days, when cell density 
reached 1 X 106 cells/mL.  Experiments were conducted with cells harvested 
between 14-28 days of culture.    
 
Cytology 
Cytospins of BMMC were prepared at intervals by centrifuging aliquots 
of cells at 500 rpm for 5 minutes (Shandon Cytospin 2).  Slides were air dried, 
stained with Alcian blue (Sigma; St. Louis, MO) for 10 minutes, and counter-
stained with Safranin-O for 10 minutes (Sigma; St. Louis, MO).  Coverslips 
were mounted with glycergel (DakoCytomation,Inc; Carpinteria, CA).  A total of 
100 cells were evaluated (stained/unstained) in high power fields (40X) of 
slides prepared from individual flasks.  The percentage of cells stained blue 
was averaged and the mean value of three flasks reported.  Slides were 
examined on an Olympus BX51 microscope and photographed with a DP-12 
digital camera system (Melville, NY).  Total cell counts were estimated from 
each of the three flasks using a hemacytometer (Reichert; Buffalo, NY). 
 
RMCP-II detection in BMMC and RBL-2H3 cell lysates 
Mouse anti-RMCP-II (21) was generously provided by Dr. Hugh Miller 
(University of Edinburgh).  BMMC were sampled on days 11 and 28 in culture 
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and lysed using 1% Triton-X 100.  RBL-2H3 cells were similarly prepared for 
comparison.  Protein concentrations of lysates were measured with the Biorad 
protein assay kit (Biorad Laboratories Inc.; Hercules, CA).  BMMC and RBL-
2H3 lysates (20 µg and 30 µg per well) were resolved in a 10% discontinuous 
sodium dodecyl sulfate-polyacrylamide reducing gel (SDS-PAGE) at 25 mÅ for 
1.25 hours.  Gels were blotted onto nitrocellulose membranes at 400 mA for 1 
hour, then blocked in DPBS supplemented with 7.5% non-fat dry milk (NFDM) 
and 0.2% Tween 20 at 4°C overnight.  Membranes were incubated with 
antibody by gently rocking for 1 hour at room temperature.  Mouse anti-RMCP-
II was diluted (1:500) in DPBS supplemented with 2% NFDM and 0.2% 
Tween-20.  The membrane was washed 5 times with DPBS and 0.2% Tween-
20.  Goat anti-rat IgG horseradish peroxidase conjugate (MP Biomedicals; 
Aurora, Oh), was diluted (1:1500) in DPBS supplemented with 2% NFDM, 
0.2% Tween 20, and 10% normal goat serum. Membranes were incubated 
and washed 5 times as before.   Antibody binding was detected with a 
chemiluminescent substrate (ECL reagent; Amersham Pharmacia Biotech; 
Piscataway, NJ) and autoradiography with Classic Blue Sensitive x-ray film 
(Laboratory Products Sales; Rochester, NY).  Film was developed in a Kodak 
X-OMAT 1000 A processor (Rochester, NY) and scanned.  The image was 
prepared using Adobe Photoshop and Microsoft Powerpoint. 
 
Flow cytometric analysis of immune complex and antigen binding 
Rat monoclonal IgG1, IgG2a, IgG2b, IgG2c (2), and polyclonal IgE (6), 
were conjugated with Alexa Fluor-488 (Molecular Probes; Eugene, OR).  
Briefly, immunoglobulins were dialyzed in PBS (pH 8.5) overnight at 4°C.  
Alexa Fluor-488 (100 µg/mL) was added to immunoglobulin (1.0 mg/mL) and 
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incubated at room temperature for 4 hours or overnight.  Samples were 
dialyzed in PBS overnight and stored with 0.1% sodium azide at 4°C in a light-
protected container until use.  Molar dye:protein ratios were estimated to be 
between 3 – 13. 
 BMMC and RBL-2H3 cells were washed in PBS three times then 
resuspended in PBS at 0.5 X 106 cells/mL.  Cells were incubated with 
conjugated immunoglobulins (10 µg/mL) for 15 minutes and then ESA or cAg 
(10 µg/mL) was added.  Cells were incubated on ice for 1 hour then washed 
three times with PBS and fixed in 2% paraformaldehyde.  In some 
experiments, Fc receptors were blocked with mouse anti-rat FcεRI or mouse 
anti-rat FcγRII (BD Pharmingen; San Diego, CA).  Blocking antibodies were 
added to cells separately or together 30 minutes prior to immune complex 
addition.  Immune complex binding was detected with a FACSCalibur flow 
cytometer (BD Biosciences; San Jose, CA) and data were analyzed using Cell 
Quest or Flow Jo software.  Figures were generated using Flow Jo and 
Microsoft Powerpoint.  
 Direct binding of ESA and cAg to cells was tested by incubating cells for 
1 hour on ice with either ESA or cAg (10 µg/mL).  We found that rat IgG2c 
immune complexes did not bind to mast cells, so rat IgG2c-Alexa 488 (10 
µg/mL) was used to detect direct antigen binding to cells.  Unbound antigen 
was removed from cells by washing with PBS and the cells were incubated 
with IgG2c for 30 minutes, washed 3 times with PBS, fixed in 2% 
paraformaldehyde, and analyzed by flow cytometry.   
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β-Hexosaminidase assay 
Degranulation was assessed by a modified colorimetric assay that 
measures β-hexosaminidase release from cells (32).  Briefly, cells were 
cultured overnight in either 48 well (2.50 X 105 cells per well) or 96 well (1.25 
X 105 cells per well) plates.  Both BMMC and RBL-2H3 cells were adherent.  
Cells were washed twice with Tyrodes buffer (20 nM HEPES, 135 mM NaCl, 5 
mM KCl, 1 mM MgCl2, 5.6 mM glucose, 0.1% BSA,  and 1.8 mM CaCl2 (pH 
7.4)).  Immunoglobulins were diluted in Tyrodes buffer, added to cells 15 
minutes prior to antigen.  Cells were incubated with complexes for 1 hour at 
37°C.  Calcium ionophores (1 µM), ionomycin (Sigma; St. Louis, MO) or 
A23187 (Sigma; St. Louis, MO), in the presence of phorbol ester-12 myristate-
13 acetate (PMA) (50 nM) (Sigma; St. Louis, MO) served as positive controls 
for cell stimulation.  For 48 well plates, 50 µl culture supernatant were 
incubated with 200 µl of 1 mM p-nitrophenyl N-acetyl-β-D-glucosaminide 
(Sigma; St. Louis, MO) dissolved in 0.05 M citrate buffer (pH 4.5) for 1 hour at 
37°C.  The reaction was stopped with 500 µL of 0.1 M sodium carbonate 
buffer.  Substrate was measured at 400-405 nm using either an Ultraspec 
2100 pro spectrophotometer (Amersham Pharmacia Biotech; Piscataway, NY) 
or an ELISA plate reader (Bio-Tek Instruments; Winooski, VT).  β-
hexosaminidase release was reported as the percent of total enzyme per well.  
Samples were run in triplicate and the means reported.  Total β-
hexosaminidase concentration was determined by extracting (1:1) the 
remaining buffer and cells with 1% Triton X-100 (Sigma; St. Louis, MO).  A 50 
µl aliquot was removed and analyzed as described.   
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Statistical analysis 
Data were evaluated by analysis of variance (ANOVA) and Scheffe’s 
comparison of means using Statistix (Analytical Software; Tallahassee, FL).  
Differences were considered statistically significant when p < 0.05. 
 
Results 
 
Culture and phenotyping of BMMC. 
Bone marrow cultures were passaged every three days for fifteen days.  
Cytospin preparations were made from aliquots collected at the time of 
passage.  Numerous, large cytoplasmic granules were detected with Alcian 
blue, indicating that BMMC developed a homogenous mucosal phenotype 
(Figure 2.1 A).  When compared to RBL-2H3 cells (Figure 2.1 B), BMMC had 
larger, more distinct granules that stained with greater intensity.  Bone marrow 
cultures contained 95% mucosal mast cells by 12 days in culture and 99% 
mucosal mast cells by 15 days (Figure 2.1 C).  Cell growth and viability 
diminished after 30 days in culture.   
RMCP-II is an enzyme found only in mucosal mast cells (15).  Cell 
lysates prepared from bone marrow cells at day 11 and 28 in culture were 
compared with lysates of RBL-2H3 cells in Western blots developed with 
antibody to RMCP-II.  A 24 kDa protein was readily detected in bone marrow 
cell lysates; however, similar protein loading of RBL-2H3 cell lysate was not 
sufficient for RMCP-II detection (Figure 2.1 D).  In addition, when equivalent 
numbers of BMMC and RBL-2H3 cells were assayed for β-hexosaminidase, 
cells in bone marrow cultures (14 days of culture or later) yielded twice the 
quantity of β-hexosaminidase when compared to RBL-2H3 cells (Figure 2.1 
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E).  We confirmed that ganglioside-specific monoclonal antibody AA4 bound to 
BMMC.  AA4 detects two derivatives of ganglioside GD1b that are unique to 
mast cells (28) and present on all rat derived mast cells including BMMC (18).  
Surface expression of GD1b was approximately 3-fold greater on RBL-2H3 
cells than BMMC (Figure 2.1 F & G).  Thus we documented that cells cultured 
from bone marrow in the presence of SCF and IL-3 were uniformly of a 
mucosal mast cell phenotype.  In subsequent experiments, we assayed cells 
harvested from cultures between 14 and 28 days and refer to these cells as 
BMMC. 
 
Specificity of immune complexes for FcR on RBL-2H3 cells and BMMC.   
Because IgG as well as IgE are protective against T. spiralis in vivo (6) and 
mast cells are implicated in immunity, we sought to ascertain whether IgG 
immune complexes could activate mast cells via Fc receptors.  We found that 
immune complexes containing IgG1, IgG2a, and IgG2b bound to both BMMC 
and RBL-2H3 cells (Figure 2.2 A) while IgG2c did not (data not shown).  By 
blocking with specific antibodies for receptors, we found that IgG1-ESA and 
IgG2a-ESA bound to FcεRI and FcγRII on both cell types (Figure 2.2 A), while 
IgG2b-ESA bound only FcγRII (Figure 2.2 A).  IgE-ESA bound to FcεRI.  
Figure 2.2 B summarizes the geometric mean fluorescence intensities of RBL-
2H3 cells and BMMC bound by immune complexes and the reduction in GMFI 
obtained when complexes were  competed with receptor-specific antibodies.  
Substitution of T. spiralis crude antigen (cAg) for ESA did not alter the 
outcome of the experiment (data not shown).  Immune complex binding was 
similar for FcRs on RBL-2H3 cells and BMMC despite the greater 
heterogeneity of receptor expression by BMMC. 
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Figure 2.1:  Comparison of properties of RBL-2H3 cells with BMMC.  
Cytospins prepared from BMMC  at 21 days in culture (A) and RBL-2H3 
cells (B) were stained with Alcian blue/Safranin-O.  (C)  Growth and 
staining properties of bone marrow cells cultured in the presence of IL-3 
and SCF.  Cells containing granules detected with Alcian blue were 
classified as mast cells.  Values represent the mean +/- 1 SD (n = 3).  
(D) Detection of RMCP-II in Western blots of BMMC and RBL-2H3 cell 
lysates.  Cells were collected from bone marrow cultures after 11 or 28 
days.  (E)  β-hexosaminidase content was quantified in cell lysates 
prepared from cells after 21 days in culture and is reported as optical 
density (OD) at 400 nm per 1.25 X 105 cells.  Values represent the 
mean +/- 1 SD (n = 12 wells).  Detection of rat mast cell specific 
ganglioside, GD1b, with FITC-conjugated antibody by flow cytometric 
analysis on (F) RBL-2H3 cells and (G) BMMC.  Unstained cells (shaded 
grey) and nonspecific IgG-FITC (grey line) served as negative controls.  
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Figure 2.2:  Flow cytometric analysis of binding by immune complexes to 
Fc receptors on RBL-2H3 cells and rat BMMC.  (A) Fluorescence 
intensity of cells treated with immune complexes.  Unstained cells (grey 
line) and monomeric IgG2c-Alexa 488 (black line) served as negative 
controls.  Binding was blocked with antibodies specific for FcεRI (red line) 
or FcγRII (orange line) separately or in combination (green line).  Dye: 
protein molar ratio for antibodies ranged from 3 to 13.  (B)  Reduction in 
geometric mean fluorescence intensity of immune complex (IC) binding to 
RBL-2H3 cells or rat BMMC in the presence of receptor blocking 
antibodies.  
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Surface expression of the inhibitory receptor FcγRII is predicted to 
affect mast cell activation by IgG2a and IgG1 immune complexes.  We found 
that IgG2b-Alexa 488 complexed with T. spiralis ESA bound exclusively to the 
inhibitory receptor on BMMC and RBL-2H3 cells.  As determined by flow 
cytometric analysis, BMMC (Figure 2.3 B) had a 4-fold greater surface 
expression of FcγRII compared with RBL-2H3 cells (Figure 2.3 A).  
Additionally, IgE-ESA immune complexes bind exclusively to FcεRI.  RBL-2H3 
cells (Figure 2.3 C) had a 4-fold greater surface expression of FcεRI than 
BMMC (Figure 2.3 D).  Thus, we find that BMMC have a lower A/I ratio than 
RBL-2H3 cells.   
  
Activation of RBL-2H3 cells and BMMC by immune complexes. 
The experiments described above showed that three isotypes of IgG 
were bound by RBL-2H3 cells and BMMC.  Next we assayed those immune 
complexes for mast cell activation.  It has been reported the IgG2a complexes 
bind and activate mast cell degranulation via FcεRI (7).  We titrated parasite 
specific IgE (0.15 to 2.5 µg/mL) and IgG2a (0.15 to 2.5 µg/mL) with ESA (1 
µg/mL).  Both isotypes caused RBL-2H3 degranulation (Figure 2.4 A).  
Optimal immunoglobulin concentration for degranulation was 2.5 µg/mL.  By 
blocking FcεRI with monomeric IgE IR 162, we confirmed that mast cell 
activation by IgG2a was mediated by FcεRI aggregation (Figure 2.4 B).  
Although IgG1 bound the FcεRI and FcγRII in a manner identical to IgG2a, it 
failed to stimulate significant degranulation in RBL-2H3 cells or BMMC above 
spontaneous β-hexosaminidase release (Figure 2.4 C).  IgG2b did not induce 
degranulation, a result that is compatible with its binding solely to the inhibitory 
receptor, FcγRII (Figure 2.4 C).   
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Figure 2.3:  Comparison of surface expression of FcγRII and FcεRI on 
RBL-2H3 (A, C) cells and BMMC (B, D).  Cells were labeled with Alexa-
488 conjugated IgG2b or IgE (10 µg/mL) complexed with ESA (10 
µg/mL) and analyzed by flow cytometry.  Immune complex binding is 
represented with a black line, conjugated monomeric IgG2c is 
represented by a grey line, and unstained cells are shaded. 
Experiments were repeated at least three times. 
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Figure 2.4:  Degranulation of RBL-2H3 cells induced by antibodies 
complexed with T. spiralis ESA.  (A) Immune complexes formed by 1 
µg/mL of ESA with increasing concentrations of IgE (    ) or IgG2a (    ) 
were incubated with RBL-2H3 cells.  (B)  Inhibition of IgG-induced 
degranulation by monoclonal IgE IR 162.  Cells were incubated with 
various concentrations of IgE prior to adding complexes formed by anti-
tyvelose IgG2a (2 µg/mL) and ESA (1 µg/mL).  Symbols represent the 
mean +/- 1 SD of triplicate samples.  (C)  RBL-2H3 cells and BMMC 
were stimulated with IgG1 or IgG2b (2.5 µg/mL) and ESA (1.0 µg/mL).  
Values represent the average of two duplicates.  Data shown are 
representative of three experiments.  
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We compared RBL-2H3 cell and BMMC activation by anti-tyvelose IgE and 
IgG2a in complex with ESA or cAg.  In addition, we tested anti-DNP IgE and 
IgG2a in complex with DNP-BSA.  We compared two different parasite antigen 
preparations in addition to DNP-BSA to determine whether differences in 
immune complex structure might enhance FcR aggregation and mast cell 
activation.  IgE complexed with ESA, cAg, and DNP-BSA stimulated significant 
cell degranulation in both RBL-2H3 (Figure 2.5 A-C) and BMMC (Figure 2.5 D-
F).  IgG2a-ESA and IgG2a-DNP-BSA induced significant degranulation in 
RBL-2H3 cells (Figure 2.5 A, C); however,  degranulation induced in BMMC 
was weak but reproducible, yet not statistically significant (Figure 2.5 D, F).  
IgG2a-cAg also did not induce significant degranulation of either RBL-2H3 
cells (Figure 2.5 B) or BMMC (Figure 2.5 E).  Treatment of RBL-2H3 cells with 
PMA or cytochalasin D prior to stimulation with immune complexes will 
enhance degranulation.  We also stimulated BMMC with immune complexes in 
the presence of PMA or cytochalasin D in an attempt to enhance 
degranulation; however, neither compound improved degranulation of BMMC 
by IgG2a complexes (data not shown).  Comparison of RBL-2H3 and BMMC 
responses to 50 nM PMA and 1 µM calcium ionophore A23187 confirmed that 
BMMC responded as well as RBL-2H3 cells to stimulation by these 
compounds (Figure 2.5 D-F).  Thus, while BMMC are capable of degranulation 
responses to IgE or ionophores, they are refractory to IgG immune complexes.   
 
Binding of parasite antigens to BMMC and effect on activation.   
In order to determine whether the poor degranulation response by 
BMMC was due to a direct effect of parasite antigens on the cells, we assayed 
binding of ESA and cAg to the surfaces of BMMC and RBL-2H3 cells.  ESA 
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Figure 2.5:  Degranulation responses of RBL-2H3 cells and BMMC. RBL-
2H3 (A-C) and BMMC (D-F) stimulation with immune complexes formed  
with IgG2a or IgE specific for tyvelose (found in ESA and cAg), or DNP-
BSA.  Antibodies (10 µg/mL) were complexed with antigens (1 µg/mL), 
except for RBL-2H3 stimulation with anti-DNP-BSA IgE and IgG2a (2 
µg/mL).  Asterisks denote values that differed significantly from the buffer 
control (p < 0.05).  Values graphed are means +/- 1 SD of three 
duplicates. 
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did not bind, while cAg bound to both cell types (Figure 2.6 A).  To determine 
whether binding influenced responsiveness of the cells, we incubated cells 
with parasite antigen before stimulation with IgE-DNP-BSA.  Treatment with 
ESA or cAg (10 µg/mL) before addition of IgE-DNP had no effect on BMMC 
degranulation (Figure 2.6 B).  
 
Discussion 
 Rat BMMC grown in the presence of IL-3 and SCF have a 
homogenous mucosal phenotype characterized by prominent granules that 
stain with Alcian blue and by RMCP-II production (16).  IgE cross-linking 
stimulates the release of RMCP-II, β-hexosaminidase, and leukotriene C4 from 
BMMC (21).  Rat BMMC also store TNF-α and upon IgE mediated stimulation 
release this cytokine (22).  Studies of these cells have demonstrated that they 
are functionally and biochemically very similar to their in vivo mucosal 
counterpart (22).  Because of this we chose to culture rat BMMC for our 
investigations concerning IgG mediated activation of mucosal mast cells.  We 
compared BMMC to RBL-2H3 cells for mucosal properties and found that, 
compared with RBL-2H3 cells, BMMC contained larger cytoplasmic  
granules that uniformly stained with Alcian blue, as well as greater quantities 
of RMCP-II and β-hexosaminidase.  Degranulation in response to stimulation 
with PMA and the calcium ionophore A23187 was equivalent for BMMC and 
RBL-2H3 indicating that BMMC were capable of degranulation after 14 days of 
culture in vitro. 
 Mast cells are implicated in immunity to T. spiralis infection, yet the 
mechanism by which they affect worm expulsion has remained undefined.  We  
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Figure 2.6:  Direct antigen binding to BMMC and RBL-2H3 cells.  (A)  
Flow cytometric evaluation of cells after incubation with antigens.  ESA 
and cAg (10 µg/mL; black line) were incubated with BMMC and RBL-2H3 
cells before addition of IgG2c-Alexa 488 (10 µg/mL).  Unstained cells are 
represented by the shaded peak and cells incubated with conjugate 
alone are indicated by grey line.  (B)  Incubation with ESA or cAg (10 
µg/mL) before addition of IgE (10 µg/mL) and DNP (1 µg/mL) did not 
significantly alter cell stimulation.  Values are reported as the mean +/- 1 
SD (n = 3).  Asterisk denotes significant differences from cells treated 
with buffer (p < 0.05).  
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hypothesized that parasite-specific IgG immune complexes might activate 
mast cells via FcRs.   Three IgG isotypes (IgG1, IgG2a, and IgG2c) are 
protective in vivo against a challenge infection with Trichinella (6).  This 
protection is not mediated by antibodies alone, but requires cooperation with 
some yet unidentified cell or co-factor.  Since mastocytosis is a prominent 
inflammatory feature of intestinal infection by T. spiralis, it is possible that 
immune complexes formed by IgG might interact with mast cell Fc receptors in 
promoting expulsion.  Protective monoclonal antibodies are all specific for 
tyvelose, a sugar that modifies the termini of tri- and tetra-antennary glycans 
on T. spiralis glycoproteins (12).  Tyvelose-specific antibodies have been 
shown to form large complexes with secreted products of T. spiralis in vitro 
(23), and are likely to be highly effective in aggregating FcRs on cell surfaces.  
We found that IgG1, IgG2a, and IgG2b bound to Fc receptors on 
BMMC and RBL-2H3 cells.  IgG2b, which is not protective in vivo, bound only 
to the FcγRII.  Consistent with the inhibitory function of this receptor, IgG2b 
complexes did not stimulate degranulation.  IgE bound only to FcεRI and 
caused degranulation in BMMC and RBL-2H3 cells.  IgG2a and IgG1 bound to 
FcεRI and FcγRII on both cell types; however, only IgG2a elicited 
degranulation on RBL-2H3 cells via the FcεRI.  IgG1 and IgG2a are very 
similar in structure and function and it is unclear why these two isotypes differ 
in their ability to activate mast cells.  Rat IgG1 has been reported to stimulate 
degranulation in peritoneal mast cells; however, these experiments were 
preformed with polyclonal IgG that was purified with polyclonal reagents (24). 
Other evidence indicates that IgG1 can function as a blocking antibody that 
inhibits IgE mediated degranulation of RBL-2H3 cells (29).  The functional 
discrepancies between IgG1 and IgG2a may be due to differences in binding 
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affinities for activating versus inhibitory FcRs.  Alternatively, there may be an 
activating FcγRII or FcγRIII that binds IgG2a exclusively that has not been 
described in rat mast cells and that our reagents fail to distinguish.  
Surface expression of the inhibitory FcγRII was greater while FcεRI 
surface expression was reduced on BMMC compared with RBL-2H3 cells.  
There is convincing evidence that FcγRII is not functional on RBL-2H3 cells (9) 
and our data support this conclusion.  We found that cross-linking the FcεRI 
and FcγRII with anti-tyvelose IgG2b and IgE did not inhibit IgE-mediated 
degranulation of RBL-2H3 cells (data not shown).  This provides a rational 
explanation for the greater response to IgG2a complexes of RBL-2H3 cells 
compared to BMMC.  Alternatively, structural properties of parasite antigen-
antibody complexes might be the reason for decreased responsiveness to IgG 
in BMMC.  To address this, we assayed immune complexes formed with other 
antigens.  We compared IgE and IgG2a complexed with DNP-BSA, ESA, and 
cAg.  IgE-DNP-BSA consistently stimulated the greatest degranulation 
response in BMMC.  IgE-ESA and IgE-cAg were active but induced weaker 
responses.  This suggests that structural differences among the antigens may 
influence receptor aggregation and mast cell stimulation.  Immune complexes 
formed with IgG2a and DNP, ESA, or cAg did not induce substantial 
degranulation in BMMC.  Differences between BMMC stimulation induced by 
IgE and IgG2a is likely attributable to BMMC expressing a lower activating to 
inhibitory (A/I) FcR ratio than RBL-2H3, as a result of greater inhibitory FcγRII 
expression and lower FcεRI expression on BMMC.  Future studies utilizing 
treatment with inflammatory cytokines to decrease expression levels of this 
receptor or RNA interference to prevent its surface expression would be 
informative for clarifying the significance of IgG in mast cell activation.   
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While it is known that mast cells express Toll-like receptors (TLRs) that 
promote or induce cytokine release (20, 31), a TLR specific for nematode 
parasite antigens has yet to be identified.  T. spiralis TSL-1 antigens trigger 
significant cytokine and histamine release from a hybrid rat mast cell line 
(HRMC) (4, 26) in the absence of immunoglobulin.  TSL-1 antigens are affinity 
purified from cAg by binding to tyvelose-specific antibody.  They are distinct in 
composition from ESA that contains only secreted products not all of which 
bear tyvelose.  The receptor that mediates activation by TSL-1 antigens has 
not been identified, nor has the physiologic significance of activation been 
determined.  In our study, we investigated other related T. spiralis antigens for 
binding to and activation of mucosal mast cells.  T. spiralis ESA did not bind to 
the surfaces of cells; however, cAg did bind to both BMMC and RBL-2H3 cells.  
We found that binding by cAg did not induce β-hexosaminidase release, nor 
did it inhibit degranulation induced by immune complexes.  Thus parasite 
antigens neither promoted nor inhibited mucosal mast cell activation.  
Although it is possible that aggregation of parasite specific immunoglobulins 
with surface bound cAg has qualitative effects on mast cell mediator release, 
β-hexosaminidase release was similar with immune complexes containing 
ESA and cAg.  This supports the conclusion that cAg did not alter 
responsiveness of cells to immune complexes.   
Mucosal mast cells in the Th2 cytokine-rich environment induced by 
parasitic infection may have Fc receptor diversity that differs from that 
displayed by BMMC.  The ability of the mast cell to change phenotype, to 
regulate Fc receptor diversity and isotype interactions, and to release a variety 
of inflammatory mediators merits further investigation in the context of 
parasitic infection.  In this report, we have demonstrated that BMMC cultured 
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in vitro are a useful model for pursuing investigations of FcR driven activation  
because of their similarity to the mucosal mast cell in situ.  Isotype specificity 
of FcRs were the similar for both RBL-2H3 cells and BMMC; however, BMMC 
had a lower A/I receptor ratio.  The lower A/I ratio, rather than structural 
features of parasite antigen-antibody complexes, resulted in sub-optimal FcR 
mediated degranulation.  Our data indicate that due to elevated expression of 
FcγRII, mucosal mast cells may be refractory to stimulation with IgG but not 
IgE.    
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Abstract 
 
Rats infected with the parasitic nematode, Trichinella spiralis, protect 
themselves against re-infection by a dramatic immune mechanism called rapid 
expulsion.  Our aim is to clarify the mechanism of IgG2a-mediated expulsion 
of T. spiralis from the intestine during challenge infection.  We hypothesized 
that IgG2a immune complexes interact with Fc receptors on leukocytes to 
promote the rapid expulsion of larvae from the intestine.  Although correlative 
evidence suggests that expulsion involves mast cells, the mechanism of 
expulsion has not been elucidated.  In previous studies, passive immunization 
of adult rats with parasite-specific monoclonal IgG2a caused expulsion of T. 
spiralis larvae within 24 hours (4).  This protective mechanism occurred only 
when rats had been previously infected with an unrelated nematode, 
Heligmosomoides polygyrus.  Infection with H. polygyrus likely activates innate 
immunity that cooperates with antibodies to cause expulsion.  We demonstrate 
here that rapid expulsion occurs in Lewis rats infected with H. polygyrus and 
passively immunized with specific IgG2a.  This immunity was associated with 
increased eosinophilia, mastocytosis, and mast cell activation.  These 
changes were more dramatic in Lewis than in AO strain rats and correlated 
with better protection in Lewis rats.  Mucus entrapment of larvae is a hallmark 
of rapid expulsion, but was not evident in IgG2a mediated expulsion.  IgG2a 
mediated protection was Fc-dependent and did not require complement.  Our 
data support an indirect influence of IgG2a in rapid expulsion that likely 
involves FcR-bearing cells.   
 
 
 
 
  68
Introduction 
   
 Rats previously infected with the parasitic nematode, T. spiralis, 
demonstrate a potent immune defense against secondary intestinal infection 
that has been called rapid expulsion (14).  Within a few hours, 99% of first-
stage larvae are expelled from the intestine (6).  Mucus entrapment of larvae 
is a hallmark of rapid expulsion (9),(4) and has been shown to be mediated by 
antibodies that are specific for tyvelose, a sugar that is unique to the first-stage 
larva.  Antibodies specific for tyvelose cause expulsion of larvae from the 
intestines of passively immunized neonatal rats.   
During primary infection, first-stage larvae in muscles induce a 
substantial tyvelose-specific antibody response.  The intestinal phase of 
infection induces goblet cell hyperplasia, mastocytosis, and eosinophilia in the 
small intestine (4).  Mechanistic studies in adult rats have shown that antibody 
is necessary but not sufficient for expulsion, and that some cellular component 
or co-factor of the immune system is required (5).  Rapid expulsion can be 
reproduced in adult rats by infection with a heterologous nematode, such as 
Heligmosomoides polygyrus, and passive transfer of Trichinella specific 
monoclonal antibodies (4).  IgG1, IgG2a, and IgG2c are all protective in this 
model but IgG2b is not.  IgG1 and IgG2c are protective in suckling rats (2) and 
these isotypes cause mucus entrapment of the parasite (8).  However, IgG2a, 
like IgE, is not protective in neonatal rats and does not entrap larvae in mucus 
(8).  In contrast, IgG2a and IgE are protective in adult rats infected with H. 
polygyrus (4), suggesting that antibodies cooperate with an innate cellular 
component to effect immunity.  It is thought that the mechanism for IgG2a 
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mediated protection is different from the other IgG isotypes but similar to that 
of IgE (4).  
 In experiments reported here, we investigated further the mechanism of 
IgG2a-mediated protective immunity.  We found that H. polygyrus infection 
alone caused limited but reproducible expulsion of T. spiralis, and this was 
associated with mast cell activation and other inflammatory changes in the 
intestine.  IgG2a was protective against T. spiralis in rats infected with H. 
polygyrus, although mucus entrapment of larvae was not prominent; however, 
the magnitude of protection approached that of rapid expulsion demonstrated 
by naturally infected rats.  Finally, IgG2a mediated protection in an Fc-
dependent but complement independent, manner.  
 
Materials and Methods 
 
Rats and mice 
Albino Oxford (AO), Lewis, PVG, LouM, and Brown Norway (BM) strain 
rats (8 to 12 weeks old) were bred and maintained in the James A. Baker 
Institute for Animal Health vivarium.  Eight week old C57BL/10SgAiTac (WT) 
or C57BL/10ScNHsd (WT) mice were purchased from Taconic Animal Models 
(Germantown, NY) or Harlan (Indianapolis, IN), respectively.  All rodents were 
housed in accordance with the guidelines of the American Association for 
Accreditation of Laboratory Animal Care.  
 
Antibodies 
Monoclonal rat anti-tyvelose IgG2a (clone 18H1.1) has been 
characterized (Appleton et al., 1988).  18H1.1 ascites was purchased from 
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Harlan (Indianapolis, IN), and normal rat serum (NRS) was collected by 
cardiac puncture from uninfected rats under isoflurane anesthesia.  Sera or 
ascites were heat inactivated at 56°C for 30 minutes before antibody 
precipitation with 40% saturated (NH4)2SO4 as described previously (9).  
Mouse anti-rat kappa chain (Mark-1) was precipitated with 40% (NH4)2SO4 
from ascites as described and biotinylated with N-hydroxysuccinimidobiotin 
(Sigma; Saint Louis, MO) in bicarbonate buffer (pH 9.5; 120 µg biotin per mg 
of antibody) for 4 hrs at room temperature.  Horseradish peroxidase (HRP) - 
conjugated goat anti-rat IgG (H&L) was purchased (MP Biomedicals; Aurora, 
Oh).   
 
Preparation of Fab’2 
Fab’2 fragments  were prepared from IgG2a according to a protocol 
modified from Rousseaux et al. (17).  Briefly, IgG2a was dialyzed in 0.1M Na 
formate (pH 2.8) for 16 hours, dialyzed in 0.1M Na acetate (pH 4.2) for three 
hours, and digested with 2% (w/w) pepsin at 37°C for four hours.  The reaction 
was stopped by dialysis in 0.1M Na acetate (pH 8.2) overnight at 4°C.  
Cleavage was confirmed by resolving fragments in 8% SDS PAGE non-
reducing gels, blotting to nitrocellulose, and developing blots with goat anti-rat 
IgG-HRP.  Binding efficiency for parasite specific IgG2a and IgG2a Fab’2 
fragments was measured by ELISA.  Briefly, polyvinyl 96-well plates were 
coated with 5 µg/mL T. spiralis crude antigen diluted in 10% Dulbecco’s PBS 
(DPBS) overnight at 4° C.  Plates were blocked with DPBS containing 7% 
non-fat dry milk (NFM).  Serial dilutions of IgG2a and IgG2a Fab’2 fragments 
in DPBS containing 2% NFM were incubated for 1 hour at room temperature.  
Biotinylated Mark-1 (2 µg/mL) diluted in DPBS was incubated for 1 hour at 
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room temperature followed by 1:1,000 dilution of HRP conjugated-strepavidin 
in DPBS (BD Pharmingen, San Diego, CA).  The plates were developed for 5 
minutes with tetramethylbenzidine (TMB) (KPL Laboratories, Gaithersburg, 
MD) and stopped with 1 M H3PO4.  Absorbance (450 nm) was measured with 
an ELISA plate reader (Bio-Tek Instruments, Winooski, VT).  Antibodies and 
Fab’2 fragments were dialyzed in 0.85% saline and stored at -20° C until use. 
  
Heligmosomoides polygyrus and Trichinella spiralis 
H. polygyrus was propagated in C57BL mice following methods 
described by Bell et al. (5).  Briefly, mice were infected by gavage with 300 
third-stage larvae (L3).  Feces were collected from mice.  Between 10 and 90 
days post-infection, mice were placed on screens above wet paper towels for 
24 hours.  Feces were collected and mixed with activated charcoal (1:3), set at 
room temperature for 7-8 days, and L3 collected by the Baerman technique.  
Trichinella first-stage larvae (L1) were recovered from muscle tissue of 
irradiated AO rats by digestion with 1% pepsin in acidified water, as described 
previously (10).  Rats had been infected for at least 28 days prior to 
euthanasia.   
The experimental protocol for immunization was modified from that 
described by Bell et al. (4).  Briefly, rats were infected orally with 250-500 H. 
polygyrus L3.  Monoclonal rat IgG2a, IgG2a Fab’2, or NRS IgG (25 mg/rat) 
was administered by intraperitoneal injection 12 or 13 days later.  Antibody 
was transferred 4 or 24 hours prior to oral infection with 500-1000 T. spiralis 
L1.  Rats were euthanized by CO2 inhalation followed by cervical dislocation 
18-24 hours post-challenge, and intestines were collected for worm burden 
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estimates 18-24 hours post-challenge (1).  The mean intestinal larvae burden 
was reported as a percentage of the dose.   
 
Histology and cytology  
Two cm sections of jejunum were collected, fixed in Carnoy’s solution 
(60% ethanol, 30% chloroform, 10% glacial acetic acid) for three hours, 
transferred to 70% ethanol, and embedded in paraffin.  For mast cell 
enumeration, sections were stained with Alcian blue (pH. 0.4) and 
counterstained with Nuclear Fast Red.  Eosinophils were counted in tissues 
fixed in 10% neutral buffered formalin and stained with hematoxylin and eosin 
(H & E).  Mucosal mast cells, and eosinophils were counted in twenty crypt-
villus units (CVU) per rat, and the means for rats in treatment groups were 
reported.   
Blood smears were fixed and stained using Protocol Hema 3 stain set 
(Fisher Scientific Company, L.L.C.; Kalamazoo, MI).  A total of 300 white blood 
cells were counted, and the percent eosinophils calculated.  The means for 
rats in treatment groups were reported.  Tissue sections and blood smears 
were examined on an Olympus BX51 microscope (Melville, NY). 
   
Distribution of larvae in the intestinal tract 
Distribution of larvae in the intestine was evaluated as previously 
described (9).  Rats were euthanized 60 to 90 minutes post-challenge.  
Luminal contents were flushed from the stomach, proximal small intestine, and 
distal small intestine with 0.85% NaCl, collected into 50 mL polypropylene 
conical tubes, and held on ice.  Larvae trapped in mucus were observed and 
counted by pressing mucus between glass slides.  Larvae free in saline were 
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considered to have been free in the lumen.  Intestines were incubated at 37°C 
for 5 hrs, and larvae migrating out of the epithelium were counted.  Parasites 
were counted with a dissecting scope (Zeiss, West Germany). 
 
Rat mast cell protease II (RMCP II) measurement 
RMCP II was detected in rat sera using the RMCP II ELISA kit 
purchased from Moredun Scientific Limited (Midlothian, Scotland).  
Concentrations (ng/ml) in sera were estimated from a standard curve following 
the manufacturer’s instructions and reported as the mean per treatment group.  
 
Complement measurement and depletion 
Rats were injected intraperitoneally with 30 IU of cobra venom factor 
(CVF) (Quidel; San Diego, CA) or an equivalent volume of sterile water, 24 
hours prior to oral infection.  C3 was measured in serum by radial 
immunodiffusion assay (RID).  Briefly, 2% SeaKem LE agarose (Cambre Bio 
Science Rockland Inc.; Rockland, ME) was melted in PBS and cooled to 58° C 
before adding 60 µg of goat anti-rat C3 (MP Biomedicals, LLC.; Solon, Ohio) 
per mL.  Thirty milliliters of agarose mixture were poured into 100 X 15 mm 
polystyrene square Petri plates (Nalge Nunc International; Rochester, NY), 
and 3 mm holes were punched evenly across the plate at 1.5 mm spacing.  
Normal rat serum was serially diluted for a standard curve and 10 µL of serum 
was delivered to each well.  Plates were set in a humidified box for 72 hours 
before measuring precipitation rings with a 1/60 inch engineering ruler.  
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Statistical analysis 
Parasite burdens and cell numbers were evaluated by analysis of 
variance (ANOVA) and Scheffe’s comparison of means using Statistix 
(Analytical Software, Tallahassee, FL).  Values were considered statistically 
significant when p was <0.05. 
   
Results 
 
Intestinal mastocytosis induced by H. polygyrus infection in different rat 
strains.   
We compared mast cell numbers in the small intestines of AO, PVG, 
Lewis, BN, and LouM rats that were naïve or had undergone H. polygyrus 
infection, passive immunization, and T. spiralis challenge.  BN rats had the 
highest basal mast cell number but responded with a minimal mastocytosis 
upon infection (Figure 3.1).  Lewis rats demonstrated the most dramatic 
mastocytosis (Figure 3.1).  Mastocytosis was limited in PVG and LouM and 
moderate in AO strain rats.  We conducted subsequent studies in Lewis and 
AO rats.   
We titrated the dose of H. polygyrus to investigate the effect of that 
infection on mastocytosis and worm expulsion.  Increasing doses of H. 
polygryus L3 induced significant nonspecific expulsion of larvae in Lewis rats 
(Figure 3.2 A).  This correlated with increasing mast cell numbers in the small 
intestine (Figure 3.2 B).  To minimize the confounding effects of nonspecific 
expulsion induced by oral infection with H. polygyrus, we used a dose of 250 
H. polygyrus L3 dose for subsequent experiments. 
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Figure 3.1:  Intestinal mastocytosis induced by H. polygyrus infection 
in different strains of rats.  Mast cell numbers were quantified in small 
intestines of naive rats or rats infected with 400 H. polygyrus, passively 
immunized with NRS IgG or anti-tyvelose IgG2a, and infected with T. 
spiralis. Asterisks denote values that were significantly higher (p < 
0.05) than those of similarly treated rats of other strains.  Values 
reported are the mean +/- 1 SD mast cell per crypt villus unit  (n = 3 - 5 
rats per group). 
 
 
  76
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2:  Dose response of cross-protection and mastocytosis 
induced by infection with H. polygyrus in Lewis rats.  (A) Intestinal 
worm burdens 24 hours post-infection with T. spiralis in Lewis 
rats given increasing numbers of H. polygyrus.  (B) Mast cells in 
intestines of rats described in A.  Asterisks denote means that 
were significantly different from all other groups (p < 0.05).  
Values are reported as mean +/- 1 SD (n = 4 - 5 rats per group). 
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Characteristics of expulsion by rats passively immunized with IgG2a.   
Passive immunization with monoclonal IgG2a of H. polygyrus infected 
Lewis rats prior to challenge resulted in 43% reduction in intestinal worms  
(Figure 3.3 A).  Limited expulsion (21% protection) occurred in the NRS IgG 
group, possibly due to cross-reactive immunity induced by H. polygyrus or to 
inflamed intestinal environment induced by that parasite.  Passively 
immunized AO rats were not significantly protected when compared to naïve 
rats (13% protection) (Figure 3.3 B).  Mast cell numbers in the small intestine 
were similar in naïve AO and Lewis rats; however, H. polygyrus infection 
induced a significantly larger mastocytosis in Lewis rats as compared to AO 
rats (Figure 3.3 C).  H. polygyrus infection induced a mild blood eosinophilia 
(Figure 3.3 D) and a significant small intestinal eosinophilia (Figure 3.3 E). 
 
Distribution of larvae in the intestinal tract.  
Limited numbers of larvae were entrapped in mucus from H. polygyrus 
infected rats, regardless of whether they received specific or irrelevant IgG 
(Figure 3.4 A).  Rats passively immunized with IgG2a either excluded larvae 
from the epithelium or encumbered them within the epithelium (Figure 3.4 B, 
C), while rats treated with NRS IgG or naïve rats allowed larvae to establish in 
the epithelium (Figure 3.4 C).  
 
RMCP-II detection in serum.   
H. polygyrus infected Lewis rats had significantly elevated RMCP-II 
serum levels 13 days post-infection (Figure 3.5 A) Lewis rats treated with NRS 
IgG and IgG2a had elevated RMCP-II serum levels 30 and 90 minutes  
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Figure 3.3:  Passive immunization of H. polygyrus-infected Lewis and 
AO rats with tyvelose-specific monoclonal rat IgG2a.  Intestinal worm 
burdens for (A) Lewis and (B) AO rats (expressed as a percentage of 
the dose) 24 hours post-challenge with T. spiralis. Data in A represent 
the means of five independent experiments (n = 3 – 8 rats/experiment).  
Data in B represent the means of three independent experiments (n = 3 
– 4 rats/experiment).  (C)  Mast cells per crypt villus unit in AO and 
Lewis rats 24 hours post-challenge.  (D)  Blood eosinophilia in Lewis 
rats 24 hours post-challenge.  (E)  Intestinal eosinophilia in Lewis rats 
24 hours post-challenge.  Bars denote significant differences between 
groups (p < 0.05).  Values represent the mean +/- 1 SD (n = 3 - 8 rats 
per group). 
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Figure 3.4:  Distribution of T. spiralis larvae in intestinal tracts of naive 
and immunized rats.  Sixty to 90 minutes post-challenge, rats were 
euthanized and stomach, proximal intestine, and distal intestine were 
washed and collected separately.  (A)  Larvae trapped in mucus.  (B) 
Larvae free in the lumen.  (C)  Larvae in the epithelium are considered 
to have successfully infected the host.  Values were reported as means 
+/- 1 SD (n = 4 rats per group).  Bars denote statistical significance 
between groups (p < 0.05). 
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Figure 3.5:  Measurement of RMCP-II in sera of immunized or naive 
Lewis rats following challenge with T. spiralis.  (A) Lewis rats were bled 
before (day 0) and after (day 13) H. polygyrus infection.  (B) Lewis rats 
infected with H. polygyrus and passively immunized with IgG were bled 
30 and 90 minutes post-challenge with T. spiralis.  Values are reported 
as the mean +/- 1 SD.  Bars represent significant differences between 
groups (n = 4 rats per group).   
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post-challenge as compared to naïve rats (Figure 3.5 B), but this difference 
was not greater than H. polygyrus infected rats.  RMCP-II in sera of IgG2a 
treated rats was not significantly greater than that of NRS IgG treated rats, 
demonstrating that IgG2a did not have a detectable effect on mast cell 
activation. 
     
Fc and C3 dependence of protection mediated by IgG2a. 
IgG2a Fab’2 (143 kDa) was found to be free of intact IgG2a (200 kDA) 
in Western blot.  When tested for binding to T. spiralis ESA in ELISA, intact 
IgG2a and Fab’2 fragments bound with similar efficiency; therefore, the 
fragments were pure and active.  Intact IgG2a conferred 44% protection, while 
NRS IgG and IgG2a Fab’2 conferred 27% and 29% protection, respectively 
(Figure 3.6 A).  Thus the Fab’2 fragments of IgG2a were not protective. 
Activation of complement is dependent upon the Fc.  RID assay 
confirmed that C3 was depleted from sera of rats treated with CVF.  We 
detected no precipitin reaction from sera of treated rats as compared with 
measurable reactions at a 1:16 dilution of sera from control rats.  When rats 
were depleted of C3 and passively immunized with IgG2a, they remained 
immune to challenge with T. spiralis (Figure 3.6 B). Therefore, complement 
was not essential for protection mediated by IgG2a. 
   
Discussion 
 
Rats respond to a challenge infection with Trichinella by expelling 99% 
of intestinal larvae within a few hours (6, 14).  Multiple rat strains display rapid 
expulsion when challenged after natural infection (3).  This immunity can be  
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Figure 3.6: The role of the Fc in protective immunity mediated by IgG2a.  
(A)  Rats were infected with H. polygyrus and passively immunized with 
intact IgG2a, Fab’2 fragments of IgG2a or intact control IgG prior to 
challenge with T. spiralis.  Unimmunized rats (naive) served as controls.  
Single asterisk denotes significant differences between NRS and Fab’2 
treated groups from naive rats, and double asterisk denotes significant 
differences between the IgG2a treated group and all other groups (p < 
0.05). (B)  Rats were treated with 30 IU of CVF or equivalent volume of 
sterile water vehicle. Bars denote significant differences between groups 
(p < 0.05).  Values are reported as the mean +/- 1 SD number of worms 
in the intestine expressed as a percentage of the dose (n = 3 – 8 rats per 
group).  
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recreated by passive immunization with IgE or certain IgG isoypes, but only in 
recipients that have previously received an oral infection with a heterologous 
nematode, such as H. polygyrus or Nippostrongylus brasiliensis (4, 13).  Since 
antibody alone is not protective, it has been thought that immune complexes 
might be interacting with some cellular component of the immune system that 
is expanded or induced by intestinal inflammation.  Prominent cellular changes 
in the intestine include a goblet cell hyperplasia, mastocytosis and 
eosinophilia.  Mast cells and eosinophils bear Fc receptors, and it is possible 
that immune complexes might be activating these cells in the inflamed 
intestine.  
We found that H. polygyrus-infected Lewis rats that were passively 
immunized with monoclonal anti-tyvelose IgG2a were protected against 
challenge with T. spiralis.  Previous experiments in AO rats passively 
immunized with IgG1, reproduced rapid expulsion (4); however, we were 
unable to replicate those results with IgG2a.  Our data show that the 
magnitude of mastocytosis induced by H. polygyrus varied among rat strains.  
This correlated loosely with immunity; however, other inflammatory changes 
such as eosinophilia were present and may contribute to immunity.  Lewis rats 
mounted the most dramatic mastocytosis in the intestine.  When Lewis rats 
were challenged, we observed some non-specific, or cross-reactive, immunity 
to T. spiralis that was induced by H. polygryus.  Titration of H. polygyrus dose 
showed that this effect was dose dependent.  Since H. polygyrus and T. 
spiralis share some antigens (16), it is possible that this protective effect is 
antigen specific.  Alternatively, protection may be due to the innate immune 
response involving mast cells and elicited by H. polygyrus.  Primary infection 
with T. spiralis induces intestinal mastocytosis.  Mast cell activation occurs 
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during expulsion of adult worms from the intestine (15), and RMCP-II and 
other mast cell mediators are detected in the blood (18) of rats only infected 
with H. polygyrus.   
 Mast cells bear the high affinity IgE receptor (FcεRI) as well as IgG 
receptors (FcγR).  While much is known about the FcεRI on mast cells, less is 
appreciated about FcγRs or how IgG isotypes, interacting with these FcγRs, 
might influence mast cell activation.  It has been demonstrated in vitro that 
IgG2a binds FcεRI and, upon aggregation by antigen, triggers mast cell 
degranulation (7).  IgG complexes also degranulate mouse mast cells via low 
affinity FcγRIII receptors; however, this has not been demonstrated in rat 
mucosal mast cells.  Human mast cells are induced by IFN-γ to express the 
high affinity IgG receptor (FcγRI), which upon aggregation with IgG triggers 
mast cell degranulation (19).  FcγRs on rat mast cells (11, 12) and specifically 
mucosal mast cells have not been fully characterized nor has their function 
during parasitic infection been investigated in vivo. 
 Tyvelose-specific IgG1 and IgG2c protect neonatal rats against T. 
spiralis but IgG2a does not (2).  Additionally IgG2a does not cause mucus 
entrapment in passively immunized neonatal rats while the other two isotypes 
do (8).  Passive transfer of IgG1 to H. polygyrus infected adult rats does afford 
protection and promotes mucus entrapment (4).  We found that IgG2a does 
not promote mucus entrapment in H. polygyrus infected adult rats.  Taken 
together, these observations support the conclusion that IgG2a functions 
differently from IgG1  to effect expulsion.  We tested the role of the Fc portion 
of IgG2a in protection and found that Fab’2 fragments do not confer protection.  
There are several possible explanations for this result.  First, IgG2a fragments 
do not have as long a half life as intact fragments; however, our challenge 
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experiments were initiated within 4 hours of antibody delivery.  Second, the Fc 
of IgG2a might be activating complement to facilitate rapid expulsion; 
however, our results show that protection is not dependent on C3.  
Alternatively IgG2a fragments may not have been distributed in concentrations 
sufficient to affect immunity.  Arguing against this explanation is the increased 
intestinal permeability, promoted by mast cell activation evident at the time of 
challenge that should allow fragments to reach the gut lumen.  Finally, 
protection could be dependent upon IgG2a binding to Fc receptors.   
Mast cells are activated during H. polygyrus infection, indicating that 
degranulation was not promoted by IgG2a.  Passive immunization with IgG2a 
and challenge with T. spiralis did not cause a detectable increase in serum 
RMCP-II.  To determine relevance of mast cells in rapid expulsion, mast cell-
deficient rats would need to be tested.  We were unable to obtain Ws/Ws 
strain rats needed to perform these experiments.   
We have demonstrated that IgG2a mediates immunity to T. spiralis 
independently of mucus and complement.  Our data support a role for the Fc 
portion of IgG2a or for FcR-bearing cells in protection mediated by IgG2a.  
The identity and necessity of these cells remains to be determined.  Mast cells 
may facilitate the delivery of antibodies to the epithelium by altering epithelial 
permeability, but mast cell activation is independent of IgG2a. 
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Abstract 
Rats previously infected with Trichinella spiralis exhibit a dramatic 
protective immunity to challenge infection that has been called rapid expulsion. 
A similar immunity is induced when rats are injected intravenously with 
newborn larvae, an infection protocol that establishes muscle infection in the 
absence of intestinal infection.  In this report, we describe results of 
experiments designed to further characterize the mechanism of immunity 
induced by parenteral infection.  Infection induced strong IgG1 and IgG2a 
antibody responses, yet caused no intestinal mastocytosis, goblet cell 
hyperplasia, or tissue eosinophilia.  Nevertheless, mast cells were activated 
during expulsion as indicated by detection of RMCP-II in serum 90 minutes 
post-challenge. Furthermore, mucus entrapment of larvae proceeded in a 
manner similar to that observed in rats immunized by prior oral infection.  This 
model of rapid expulsion demonstrates that parenteral immunization induces a 
pronounced mucosal immunity in the intestine that engages mast cells.  
   
Introduction 
Parasitic nematodes are a persistent global problem for people and 
livestock.  In the context of ongoing concerns regarding drug resistance in 
nematodes (22), vaccination against parasitic infection has renewed 
relevance.  Understanding immunity to intestine-dwelling nematodes has been 
advanced by studies in laboratory animals, including Trichinella spiralis in rats.  
Rats infected with T. spiralis are protected against secondary infections.  This 
potent mucosal immunity has been referred to as rapid expulsion (11).   
Rapid expulsion is a protective immunity against T. spiralis that 
eliminates as many as 99% of intestinal larvae within hours of challenge (11, 
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17, 29) and is observed exclusively in rats (3). There is substantial evidence 
that antibody plays a crucial role in protection.  Rat pups suckling a T. spiralis-
infected foster dam demonstrate rapid expulsion, and immunity is conferred by 
parasite-specific antibodies in the milk (6,5).  Passive transfer of parasite-
specific monoclonal antibodies is protective as well.  While these data provide 
strong evidence for the role of antibody in suckling rats, passive transfer of 
monoclonal antibodies or immune serum fail to promote expulsion in weaned 
rats (35).  Passively immunized adult rats demonstrate rapid expulsion only 
when “primed” by an intestinal infection with an unrelated nematode such as 
Heligmosomoides polygyrus (10) or Nippostrongylus brasiliensis (23).  It is 
thought that inflammatory changes in the intestine are required for antibodies 
to realize their protective function in adult animals. 
Mast cells have been implicated in rapid expulsion because intestinal 
mastocytosis is induced by primary infection with T. spiralis (41), and rat mast 
cell protease-II (RMCP-II) is released coincident with expulsion of adult worms 
(41) and challenge larvae (34).  Compounds released by mast cells during 
expulsion cause changes in the intestinal environment that may inhibit parasite 
establishment.  RMCP-II (36), prostaglandins (43), serotonin (28), leukotrienes 
(34), histamine (43), and cytokines (24) affect intestinal secretion (18), 
permeability (14), and smooth muscle contraction (39).  Any of these events 
may promote worm expulsion, although none of them have been proven to 
mediate rapid expulsion.  
Rats injected intravenously with T. spiralis newborn larvae (NBL) 
develop muscle infections and demonstrate strong immunity to oral infection 
(5, 12).  This immunization protocol circumvents direct stimulation of the many 
inflammatory changes induced by worms in the intestine.  In this report, we 
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describe results of experiments designed to determine whether immunity 
induced by parenteral infection is the equivalent of rapid expulsion and to 
further characterize the mechanism of immunity. 
 
Materials and Methods 
Rats and mice 
Female Albino Oxford (AO) and Lewis strain rats (8 to 12 weeks old) 
were bred and maintained in the James A. Baker Institute for Animal Health 
vivarium.  All rodents were housed in accordance with the guidelines of the 
American Association for Accreditation of Laboratory Animal Care.  Blood was 
collected from tails of rats anesthetized with isoflurane.  
 
Trichinella spiralis  
Trichinella spiralis was maintained in irradiated AO rats as decribed by 
Crum et al. (19). Mature first-stage larvae were recovered by digestion with 
1% pepsin in acidified water, and newborn larvae (NBL) were recovered from 
cultures of adult worms as described (5).   
Parenteral infections were established by injecting 80,000 NBL into the 
lateral tail vein. Control groups included naïve, uninfected rats, or rats that had 
been infected orally with 1,000 L1.  Rats were challenged orally with 500 T. 
spiralis L1 60-90 days following the primary infection.  Rats were euthanized 
by CO2 inhalation followed by cervical dislocation.  Intestines were collected 
for worm enumeration 18 - 24 hours post-challenge unless otherwise specified 
(4).  Muscle burdens were determined by counting larvae freed from 
carcasses by digestion with pepsin in acidified water.  Larval suspensions from 
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each rat were sampled three times in order to estimate total parasite burden.  
Parasites were counted with a dissecting microscope (Zeiss, West Germany).   
 
Distribution of larvae in the intestinal tract 
In order to evaluate entrapment of intestinal larvae in mucus, rats were 
euthanized 60 to 90 minutes post-challenge; and the contents of the stomach, 
proximal small intestine, and distal small intestine were examined as 
previously described (16).  Briefly, intestinal contents were flushed with 0.85% 
NaCl, collected into 50 mL polypropylene conical tubes, and packed on ice.  
Larvae trapped in mucus were observed by pressing mucus between glass 
slides.  Larvae free in saline were considered to have been free in the lumen.  
Intestines were incubated at 37°C for 5 hours, and larvae migrating out of the 
epithelium were counted.   
 
Histology and cytology   
Two cm sections of jejunum were collected, fixed in Carnoy’s solution 
(60% ethanol, 30% chloroform, 10% glacial acetic acid) for three hours, 
transferred to 70% ethanol, and embedded in paraffin.  For mast cell 
enumeration, sections were stained with Alcian blue (pH 0.4) and 
counterstained with Nuclear Fast Red.  Alternatively, goblet cells were 
enumerated in sections stained with hematoxylin and eosin (H & E).  
Eosinophils were counted in tissues fixed in 10% neutral buffered formalin and 
stained with H & E.  Mucosal mast cells, goblet cells, and eosinophils were 
counted in twenty crypt-villus units (CVU) per rat, and the mean number per 
CVU for rats in treatment groups were reported.        
  95
Blood smears were fixed and stained using Protocol Hema 3 stain set 
(Fisher Scientific Company, L.L.C.; Kalamazoo, MI).  A total of 300 white blood 
cells were counted, the percent eosinophils calculated, and reported as a 
mean for each treatment group.  Tissue sections and blood smears were 
examined on an Olympus BX51 microscope (Melville, NY). 
 
Measurement of RMCP-II in serum 
RMCP-II was detected in rat sera using the RMCP-II ELISA kit 
purchased from Moredun Scientific Limited (Midlothian, Scotland).  
Concentrations (ng/ml) in sera were estimated from a standard curve and 
reported as the mean per treatment group.  
 
ELISA for rat IgG isotypes and IgE  
Parasite-specific immunoglobulins were quantified by ELISA.  
Antibodies were detected with biotinylated monoclonal mouse anti-rat IgG1 
(RB11/39), IgG2a (RG7/1), IgG2b (RG7/11) (37), or IgE (MARE-1).  
Antibodies were biotinylated with N-hydroxysuccinimidobiotin (Sigma; St 
Louis, MO) in bicarbonate buffer (pH 9.5; 120 µg biotin per 1 mg of antibody) 
for 4 hours at room temperature.  Biotin-conjugated anti-rat IgG2c and anti-rat 
IgM antibodies were purchased (BD Pharmingen; San Diego, CA).  Standard 
curves for IgG1, IgG2a, IgG2b, IgG2c and IgM utilized parasite-specific 
monoclonal antibodies 9D4, 18H1, 10G11, 9E6 (7), and 305D9 (15), 
respectively. 
All incubations were carried out for 1 hour at room temperature.  96-well 
polyvinyl plates were coated with 1µg/mL of T. spiralis excretory-secretory 
antigen (ESA) (8) diluted in 10% Dulbecco’s PBS (DPBS) and incubated 
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overnight at 4°C.  Plates were blocked with DPBS containing 0.2% gelatin.  
Sera from rats were diluted 1:6,000 for measuring IgG1 and IgG2a, 1:100 or 
1:500 for IgG2b, 1:2500 for IgG2c, and 1:500 or 1:2500 for IgM.  Biotin-
conjugated anti-rat isotypes were diluted in DPBS containing 0.1% gelatin and 
10% normal mouse serum and used at the following concentrations: IgG1, 
IgG2a, IgG2b (1 µg/mL), IgG2c and IgM (0.25 µg/mL).  Streptavidin-
horseradish peroxidase (0.2 µg/mL), (BD Pharmingen; San Diego, CA) was 
diluted in DPBS containing 0.1% gelatin.  The plates were developed for 5 
minutes with tetramethylbenzidine (TMB) (KPL Laboratories, Gaithersburg, 
MD) and stopped with 1 M H3PO4.  Absorbance (450 nm) was measured with 
an ELISA plate reader (Bio-Tek Instruments, Winooski, VT).  In order to 
measure total serum IgE, ELISA plates were coated with anti-rat IgE mAb A2 
(5 µg/ml), rat myeloma IgE 162 served as a standard, rat sera were diluted 
1:100, and biotin-conjugated MARE-1 (5 µg/mL) was used as the detection 
reagent. 
 
Complement measurement and depletion  
C3 was measured in serum by radial immunodiffusion assay (RID).  
Briefly, 2% SeaKem LE agarose (Cambre Bio Science Rockland Inc.; 
Rockland, ME) was melted in PBS and cooled to 58°C before adding 60 µg of 
goat anti-rat complement C3 (MP Biomedicals, LLC.; Solon, Ohio) per mL of 
agarose mixture.  Thirty milliliters of agarose mixture were poured into 100 X 
15 mm polystyrene square Petri plates (Nalge Nunc International; Rochester, 
NY), and 3 mm holes were punched evenly across the plate at 1.5 mm 
spacing.  Normal rat serum was serially diluted for a standard curve.  Plates 
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were set in a humidified box for 72 hours before measuring precipitation rings 
with 1/60 inch engineering ruler.  
Rats were injected intraperitoneally with 30 IU of cobra venom factor 
(Quidel; San Diego, CA) or an equivalent volume of sterile water 24 hours 
prior to oral challenge with T. spiralis.  C3 was assayed in serum collected 
from rats 18 - 24 hours post-challenge. 
 
Statistical analysis 
Parasite burdens and cell numbers were evaluated by analysis of 
variance (ANOVA) and Scheffe’s comparison of the means or by Student’s t 
test using Statistix (Analytical Software; Tallahassee, FL).  Values were 
considered statistically significant when p was <0.05.   
 
Results 
Life-stage specificity of immunity induced by parenteral infection. 
To determine whether protection conferred by parenteral infection was 
specific for first-stage larvae, we evaluated intestinal burdens 24 and 72 hours 
following oral challenge (Figure 4.1).  Parenterally infected AO rats expelled 
86% of larvae by 24 hours.  No additional larvae were expelled between 24 
and 72 hours, demonstrating that immunity was specific for L1 and consistent 
with rapid expulsion.  Recovery of larger numbers of worms from naïve rats at 
72 versus 24 hours was likely the result of the failure of molting larvae, present 
at 24 hours post-infection, to emerge from the epithelium (35).    
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Figure 4.1:  Specificity of immunity induced by parenteral infection.  
AO rats injected with 80,000 T. spiralis NBL were challenged orally two 
months later with 500 T. spiralis first-stage larvae.  Intestinal worm 
burdens were determined 24 and 72 hours post-challenge and are 
reported as the mean +/- 1 SD (n = 4 - 5 rats per group).  Asterisks 
denote significant differences (p < 0.05) between immunized and naive 
rats.    
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Entrapment of larvae in mucus during expulsion. 
Mucus entrapment of larvae is a hallmark of rapid expulsion.  We 
compared two strains of rats, AO and Lewis, because the protection conferred 
by oral infection with a heterologous nematode was significantly different in the 
two strains (see Chapter 3).  Both parenterally and orally infected rats 
demonstrated mucus entrapment of intestinal larvae at 60 minutes post-oral 
challenge (Figure 4.2 A, D) and excluded larvae from the epithelium (Figure 
4.2 B-F).  Naive rats did not entrap significant numbers of larvae in mucus 
(Figure 4.2 A, D) and allowed large numbers of larvae to enter the epithelium 
(Figure 4.2 C, F).  Larvae free in the lumen were similar for all groups (Figure 
4.2 B, E).  No differences were observed between strains, nor were the 
kinetics of entrapment and exclusion different between orally and parenterally 
immunized rats. 
 
Effects of parenteral infection on intestinal mastocytosis, goblet cell 
hyperplasia, and eosinophilia.   
Intestinal mastocytosis and goblet cell hyperplasia are prominent in 
orally infected rats (10, 32). Lewis and AO strain rats differ markedly in the 
magnitude of mastocytosis induced by nematode infection (see Chapter 3).  
Both AO and Lewis rats demonstrated rapid expulsion following parenteral 
immunization and challenge (Figure 4.2 & 4.3 A, F).  When parenterally 
infected, neither strain exhibited appreciable intestinal mastocytosis (Figure 
4.3 B, G) or goblet cell hyperplasia (Figure 4.3 C, H).  Blood eosinophilia was 
evident 2 weeks post-oral infection in Lewis rats (Figure 4.3 I), and at 2, 4, and 
6 weeks post-oral infection of AO rats (Figure 4.3 D).  In both strains,  
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Figure 4.2:  Distribution of larvae in parenterally immunized AO (A - C) 
and Lewis (D - F) rats.  P = parenteral infection, O = oral infection, and 
N = naive. Sixty to 90 minutes post-challenge, rats were euthanized 
and stomach, proximal small intestine, and distal small intestine 
contents were washed and collected separately.  Worms free in saline 
were counted as lumenal worms (B, E).  Worms that migrated into 
saline during 5 hours incubation at 37°C were counted as epithelial 
worms (C, F).  Bars denote significant differences (p < 0.05) between 
groups.  Values reported are the means +/- 1 SD (n = 4 - 5 rats). 
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Figure 4.3:   Intestinal mastocytosis, goblet cell hyperplasia, eosinophilia 
or peripherial blood eosinophilia in parenterally infected or naïve AO (A - 
E) or Lewis rats (F - I).  Values shown are means +/- 1 SD for treatment 
group (n = 4 – 16 rats per group).  Asterisk denotes significant 
differences (p < 0.05) between groups.   
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eosinophilia had resolved by the time of challenge (Figure 4.3 D, I).  A modest 
blood eosinophilia was demonstrated at 4 and 8 weeks post-parenteral 
infection in AO rats.  Eleven weeks post-infection, eosinophils were numerous 
in the intestines of orally infected rats but not parenterally immunized rats 
(Figure 4.3 E).   
 
Dectection of RMCP-II in serum following challenge of parenterally and orally 
infected rats.   
Mast cell degranulation and RMCP-II release occurs during rapid 
expulsion induced by prior oral infection (34).  Despite the absence of 
detectable mastocytosis in the small intestine, parenterally immunized AO rats 
had significantly elevated serum RMCP-II at 90 minutes post-challenge 
(Figure 4.4 A). Challenge of naïve rats did not induce release of RMCP-II into 
the blood.  Parenteral infection did not cause an elevation of RMCP-II in blood; 
rather, serum RMCP-II in infected Lewis rats at 2, 4, and 6 weeks post-
infection was equivalent to values in naïve rats (Figure 4.4 C).  AO rats had 
significantly reduced RMCP-II concentrations in sera at 6 weeks post-infection 
when compared to naïve rats (Figure 4.4 B).  Orally infected Lewis rats initially 
had elevated RMCP-II concentrations 2 weeks post-infection, but this resolved 
by 4 weeks and increased again 1 hour post-challenge (Figure 4.4 C).   
 
Isotype profiles of antibody responses in parenterally and orally infected rats. 
Antibody production in rats orally infected with T. spiralis has been 
documented, but not quantified (4).  Because antibody contributes significantly 
to rapid expulsion of T. spiralis in suckling rats and has been implicated in 
immunity in adult rats, we quantified the isotype response to parenteral  
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Figure 4.4:  Detection of serum RMCP-II during oral or parenteral 
infection and rapid expulsion.  RMCP-II was measured by ELISA.  (A)  
Detection of serum RMCP-II following oral challenge of parenterally 
infected or naïve AO rats.  (B)  Parenterally infected AO rats and (C) 
parenterally and orally infected Lewis rats were bled at 2, 4, 6, and 8 
weeks post infection.  Dotted line represents RMCP-II concentrations 
in sera collected from unchallenged naive rats.  Values are reported 
as the mean +/- 1 SD (n = 4 – 8 rats per group).  Asterisks denotes 
significant differences (p < 0.05). 
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infection (Figure 4.5).  The most dramatic differences between orally and 
parenterally  infected rats were in parasite-specific IgG2a and total IgE.  
Parenterally infected rats produced significantly more IgG2a and IgG1 and 
significantly less IgE compared to orally infected rats (Figure 4.5 C).     
 
Effect of complement depletion on rapid expulsion in parenterally infected rats. 
Since parenteral infection induced antibodies that are capable of fixing 
complement (IgG1 and IgG2a), we tested the role of complement in rapid 
expulsion.  RID assay confirmed that C3 was depleted from sera of rats 
treated with CVF.  We detected no precipitin reaction from sera of treated rats 
as compared with measurable reactions at a 1:16 dilution of sera from control 
rats.  Treatment with CVF had no effect on rapid expulsion and did not alter 
parasite establishment in naïve rats (Figure 4.6).   
 
 Discussion 
Rats respond to oral challenge infection with T. spiralis by expelling 
99% of first-stage larvae within a few hours (11). Prominent cellular changes 
induced in the intestine by a primary infection include mastocytosis, goblet cell 
hyperplasia, and eosinophilia (10).  Mast cell activation releases inflammatory 
mediators, such as histamine, serotonin, prostaglandins, and proteases, that 
are measurable in serum during rapid expulsion (42), and cause increased 
intestinal secretion, permeability, and muscle contraction.  However, 
pharmacologic inhibition of various mast cell mediators and the consequent 
decreases in intestinal fluid secretion, fail to impede worm expulsion (13, 42). 
This demonstrates that secretion is not the mechanism of expulsion.  
Nevertheless, other mast cell mediators and their effects may promote rapid  
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Figure 4.5:  Antibody isotypes produced in response to infection with 
T. spiralis.  Antibodies of each isotype were quantified in sera of AO 
rats that were orally infected with 1,000 T. spiralis ML (grey columns, 
O) or parenterally immunized with 80, 000 T. spiralis NBL (white 
columns, P).  Sera were collected 8 weeks following oral infection and 
10 weeks following parenteral immunization. IgG1, IgG2a, IgG2b, 
IgG2c, and IgM concentrations reflect antigen-specific antibodies (A, 
B), while IgE concentrations are the total serum IgE (C).  Values are 
reported as the mean +/- 1 SD (n = 5 rats per group).  Bars represent 
significant differences between groups (p < 0.05). 
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Figure 4.6:  Effect of C3 depletion on rapid expulsion induced by 
parenteral infection.  AO rats were treated with 30 IU of CVF or with 
equivalent volume of sterile water.  Values are reported as the mean 
+/- 1 SD (n = 4 rats per group).  Asterisks mark significant differences 
between groups (p < 0.05).  
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expulsion.  In order to eliminate inflammatory and architectural changes 
induced by a primary oral infection,that may not contribute to rapid expulsion, 
we set out to characterize immunity that is induced by parenteral infection.   
Parenteral infection with T. spiralis NBL induced immunity that shared 
three prominent features of rapid expulsion.  Immunity was specific for the 
infectious first-stage larva (5), mucus entrapment occurred within 60 minutes 
of challenge (16), and mast cells were activated during expulsion (34).  
Immunity conferred by parenteral infection is consistently robust and mirrors 
rapid expulsion observed after natural infection.  Immunity induced by models 
employing oral immunizations do not reproduce the magnitude of protection 
demonstrated here (10, 23, 1).   
Rapid expulsion is specific for the infectious first-stage larva.  In 
suckling rats, immunity is provided by passive transfer of antibodies specific 
for tyvelose (7).  Tyvelose is a dideoxyhexose occupying a terminal position on 
multi-antennary N-glycans (21).  The glycans modify glycoproteins that are 
synthesized exclusively by L1.  Within 6-8 hours of entry into the intestine, 
first-stage larvae molt, and specific immunity conferred by antibodies to 
tyvelose no longer functions.  Our data demonstrated that rapid expulsion 
induced by parenteral immunization occurs within hours and is specific for L1; 
however, oral and parenteral infection induced distinctive antibody isotype 
profiles.  Oral infection induced strong IgG1 and IgE responses with little 
IgG2a.  In contrast, parenteral immunization induced elevated IgG1 and IgG2a 
and little IgE (40).  This modified Th2 response is often observed in chronic 
helminth infections.  IgG2a and IgE share functional properties and may 
perform the same role in each model of immunity. 
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A second feature of rapid expulsion is the immediate entrapment of 
larvae in mucus (10).  Previous studies have shown that IgG1, IgG2a, and 
IgG2c promote mucus entrapment of larvae in vitro (15), while only IgG1 and 
IgG2c cause mucus entrapment in vivo (16).  Mucus entrapment alone or in 
coordination with antibody (16, 15, 31), along with goblet cell hyperplasia (32, 
33) is known to play a role in rapid expulsion of N. brasiliensis in the rat.  
Mucus entrapment occurs during rapid expulsion of T. spiralis but may not be 
necessary for expulsion (9).   Entrapment is reversible in weaned rats (35), 
and we have concluded previously that it is not essential to rapid expulsion. 
Both routes of infection induced a strong IgG1 response.  In passively 
immunized suckling rats, IgG1 induces dramatic entrapment of larvae in 
mucus (15, 16).  We speculate that mucus entrapment in parenterally infected 
rats may be mediated by tyvelose-specific IgG1.   
Finally, mast cells were activated during rapid expulsion in parenterally 
immunized rats, as demonstrated by detection of RMCP-II in serum 60-90 
minutes post-challenge.  RMCP-II is unique to mucosal mast cells.  Unlike 
orally infected rats, mast cell activation induced in parenterally infected rats 
occurred without intestinal mastocytosis.  We speculate that T cell activated by 
chronic muscle infection may alter the intestinal environment.  Larvae 
colonized the tongue in parenterally infected rats, and the tongue is part of the 
mucosal associated lymphoid tissue (MALT).  T cells, activated in the cervical 
lymph nodes (CLN) by larvae that colonize the tongue, may migrate to the 
intestine and influence cells resident in the intestine.  In humans mast cell-T 
cell cross-talk mediated by OX40-OX40L has been demonstrated within the 
tonsils (26) and OX40L has the ability to induce naïve CD4+ T cell 
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differentiation to Th2 cells.  It is possible that activated T-cells migrating to the 
intestine influence mast cell activation despite the absence of mastocytosis.   
Rats demonstrate a pronounced eosinophilia in response to oral 
infection with T. spiralis (20).  We found that parenteral immunization induced 
a moderate blood eosinophilia in AO rats, but not in Lewis rats.  Intestinal 
eosinophilia was not evident in either strain.  Therefore, expanded numbers of 
intestinal eosinophils is not essential for rapid expulsion. 
Experimental designs used for modeling rapid expulsion have utilized 
oral infection with heterologous nematodes, such as H. polygyrus or N. 
brasiliensis, combined with passive transfer of parasite-specific serum, or 
monoclonal antibodies (13, 10, 23).  Protection conferred in these systems is 
never as profound as that seen in natural infection or in parenteral 
immunization.  Immunity conferred by H. polygyrus infection with passive 
transfer of antibody provides protection levels of only 65-74% (10).  Protection 
induced by parenteral immunization was 92-95%, nearly equivalent to 99% 
protection provided by natural infection.  In addition, this protection was 
demonstrable between 8 and 12 weeks and longer post-immunization, a 
period similar to that associated with oral infection. 
In another model, OX38+, OX8-, OX22- T helper cells isolated from the 
thoracic duct of T. spiralis infected rats were transferred with either immune 
serum or antibody to naïve rats (1).  This model achieved only 40-60% 
protection.  Interestingly, transfer of OX22- cells induced intestinal eosinophilia 
while transfer of OX22+ cells induced mastocytosis.  Since OX22+ did not 
protect rats from a challenge infection, it was concluded that mast cells did not 
play a role in expulsion.  Mast cell activation was not assayed in those 
experiments and, as we have demonstrated here, mast cell activation can 
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occur in the absence of mastocytosis.  Parenteral immunization is an 
advantageous model for studying rapid expulsion because it not only 
eliminates the confounding effects of intestinal inflammation but also confers 
consistently robust protection.  
Other studies of immunity to a primary infection with T. spiralis have 
implicated alterations in gastrointestinal motility in expulsion.  In these 
experiments, CD4+ T cells promoted muscle hypertrophy and increased 
contractility leading to parasite expulsion (38).  Cytokines, particularly TGF-β1, 
upregulate COX-2 and PGE2 which maintain muscle hypercontractility that 
persists as long as 6 weeks post-infection and in the absence of ongoing 
mucosal inflammation (2).  The lack of intestinal inflammation and longevity of 
muscle hypercontractility make this an attractive candidate mechanism for 
expulsion induced by parenteral immunization.  It would be informative to 
investigate whether persistent muscle hypercontractility occurs as a result of 
parenteral infection, and whether it persists in the rat long enough to account 
for immunity observed 8 to 12 weeks post-immunization.   
Our data show that parenteral infection stimulates a potent immune 
response in the intestine.  It is possible that NBL, migrating through the lung, 
induced a mucosal immune response that was transferred to the intestine.  It 
is also possible that muscle larvae residing in the tongue provide an antigenic 
stimulus that directs lymphocytes to other mucosal sites.  Mucosal 
lymphocytes up-regulate homing molecules, such as α4β7 or αEβ7  and 
CCR9, that facilitates lymphocyte migration to the intestine (27).  Alternatively, 
since parenteral infection establishes a persistent muscle infection (60 days in 
our experiments), systemic activation of lymphocytes might also somehow 
induce trafficking to mucosal sites.  Recent studies suggest that parenteral 
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vaccination can lead to mucosal immunity by up-regulating adhesion 
molecules specific for mucosal tissues (25, 30).  Our model provides an 
excellent system for further investigation of systemic priming of mucosal 
immunity.    
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The intention of this investigation was to clarify the role of mast cells in 
rapid expulsion of Trichinella spiralis from the intestine of the rat.  Rapid 
expulsion is a protective immunity against infection with T. spiralis that 
eliminates as many as 99% of intestinal larvae within hours of challenge and is 
observed exclusively in rats (1, 12).  There is an extensive body of research 
characterizing this immune response, but a comprehensive mechanism of 
immunity has not been defined.  It is known that rapid expulsion is specific for 
the infectious first stage larva (L1), and the kinetics of the immune response is 
similar to a Type I hypersensitivity reaction in that it is initiated within minutes 
and completed within hours (2, 9).  Mucus entrapment of larvae is a hallmark 
of rapid expulsion; however, mucus entrapment is reversible (7, 8, 16) and not 
essential to the process (3).  Antibodies against the highly immunogenic 
sugar, tyvelose, that modifies the L1 ESA have been shown to participate in 
rapid expulsion (4).  The requirement for anti-tyvelose antibodies proves the 
L1 specificity of the immune response. Additionally, it has been observed that 
an inflammatory infiltrate in the intestine is necessary for passive transfer to be 
effective in adult rats but not neonatal rats (4).  Primary infection with T. 
spiralis induces profound intestinal mastocytosis, eosinophilia, and goblet cell 
hyperplasia.  Parasite specific antibodies have the potential to interact directly 
with any of these cell types via Fc receptors, yet this has not been directly 
documented.  Because mastocytosis is such a prominent feature of T. spiralis 
infection, many studies of rapid expulsion have focused on the effects of mast 
cell mediators on expulsion.  While it is documented that mast cells are 
activated during rapid expulsion (13), pharmacologic inhibition of several mast 
cell mediators have failed to impede worm expulsion (5).  5-hydroxy-
tryptamine (5-HT) is one exception.  Inhibition of 5-HT did impair expulsion 
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(23), and it was speculated that this was due to the effect of 5-HT on intestinal 
secretion.  However, changes in intestinal Cl- secretion are not essential (23).  
Smooth muscle hypertrophy and hypercontractility occur as a result of parasite 
induced intestinal inflammation and certainly could contribute to worm 
expulsion (21); however, immunity conferred by T. spiralis infection is long-
lived, and it is likely that these smooth muscle changes do not persist for the 
same period.  The documented importance of antibodies and the apparent 
need for intestinal inflammation to effect rapid expulsion, support a hypothesis 
that tyvelose-antibody complexes activate mast cells via Fc receptors. 
This hypothesis was tested in a model in vitro system that assays 
binding and activation of mucosal mast cells by immune complexes.  Bone 
marrow derived mast cells (BMMC) from the rat are functionally and 
biochemically very similar to mucosal mast cells (11).  Experiments described 
in Chapter Two confirmed that BMMC displayed a homogenous mucosal 
phenotype that was superior to other mast cell models: peritoneal cells, RBL-
2H3 cells, and mouse BMMC.  BMMC contained large, distinct granules that 
bound Alcian blue, a dye that is specific for mucosal mast cells in the rat.  
Additionally, BMMC contained rat mast cell protease-II (RMCP-II), a protease 
found exclusively in mucosal mast cells.  In comparison to RBL-2H3 cells, 
BMMC contained twice the amount of β-hexosaminidase, an enzyme released 
by mast cells when they degranulate.  The mast cell specific ganglioside GD1b 
was present on the surfaces of both RBL-2H3 and BMMC.  Thus, rat bone 
marrow cells cultured with SCF and IL-3 displayed a mucosal mast cell 
phenotype. 
Comparison of immune complex binding by BMMC and RBL-2H3 
revealed that isotype specificity of FcR was the same on both cells types.  
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Immune complexes containing IgE and IgG2b bound exclusively to the FcεRI 
and FcγRII, respectively, while those containing IgG1 and IgG2a bound both 
receptors.  IgG2c immune complexes did not bind to the surfaces of either cell 
type.  These flow cytometric studies revealed that surface expression of the 
inhibitory receptor, FcγRII, on BMMC was four times that of RBL-2H3 cells, 
while the surface expression of the activating receptor, FcεRI, on BMMC 
decreased four-fold compared to RBL-2H3 cells.  Thus the potential 
activation/inhibitory ratio of FcRs on BMMC is much lower than for RBL-2H3 
cells (14).  Stimulation with IgE or IgG2a containing immune complexes 
induced RBL-2H3 degranulation regardless of whether they were complexed 
with parasite antigen or DNP-BSA (6); however, IgG2a immune complexes of 
either specificity did not significantly stimulate BMMC.  Structural differences 
between parasite antigens and DNP-BSA did not account for the lack of 
BMMC activation, as IgG2a-DNP-BSA also failed to elicit a strong response.  It 
has been reported that tyvelose bearing glycoproteins bind to the surfaces of a 
rat mast cell line, HRMC.  Such binding may affect the responsiveness of mast 
cells to FcR engagement.  We tested surface binding of the two parasite 
antigens, ESA and T. spiralis crude antigen (cAg), used to form immune 
complexes.  ESA did not bind to cell surfaces, but cAg bound to both BMMC 
and RBL-2H3 cells.  Incubating ESA and cAg with the cells prior to stimulation 
with IgE-DNP-BSA did not affect degranulation.  Thus, BMMC are likely 
refractory to IgG stimulation because of their high surface expression of FcγRII 
that contributes to a low A/I ratio on these cells.   
FcR expression on cells is known to be influenced by cytokines.  For 
example, IFN-γ causes human mast cells to express FcγRI (15).  Treatment of 
B-cells with IL-4 has been shown to decrease FcγRII expression (18).  In 
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addition, treatment of human monocytes with either Th1 or Th2 cytokines 
dramatically alters both activating and inhibitory Fc gamma receptors on the 
cell surface (17).  It would be informative to grow BMMC in the presence of 
different cytokines known to be upregulated in parasitic infection, such as IL-
4,IL-13, IL-9, IL-10, or TGF-β, and then assay FcR expression and activation 
by IgG immune complexes.  Alternatively, one could use RNAi to eliminate the 
FcγRII receptor prior to testing activation by IgG immune complexes.  
Attempts to block this receptor with a specific antibody did not effect IgG2a 
stimulation of BMMC or RBL cells (data not shown).  
IgG2a is protective when used for passive immunization of adult rats in 
experimental models of rapid expulsion.  We decided to study its mechanism 
of action in vivo, using Heligmosomoides polygyrus infection together with 
passive immunization to induce rapid expulsion (4).  By testing several rat 
strains in this model, we found that the potency of expulsion correlated with 
intestinal mastocytosis.  We chose Lewis rats for our investigations because 
this strain displayed pronounced rapid expulsion and mounted the greatest 
intestinal mastocytosis.  Titration of the H. polygyrus dose correlated with 
nonspecific immunity to T. spiralis, either due to cross-reactive antibodies or to 
the hostile environment generated in the intestine.  To eliminate the 
confounding effects of this nonspecific immunity, we used a lower dose of H. 
polygyrus for our investigations. We concluded that IgG2a did not cause 
entrapment of larvae in mucus.  IgG2a mediated protection occurred in the 
absence of mast cell activation above that induced by H. polygyrus infection 
alone; however, IgG2a-mediated protection was dependent on the Fc portion 
of the molecule.  Protection did not require complement and the results 
suggest that IgG2a may interact with FcR-bearing cells.  Additional studies 
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using Ws/Ws rats that are deficient in mast cells or rat treatment with the mast 
cell stabilizer, doxantrazole, would be useful to determine whether or not 
IgG2a might be directly interacting with mast cells.  We were unable to obtain 
these rats.  The development of knock-out and transgenic rats would also be 
advantageous to these investigations; however, it will be some time before 
such laboratory animals become available.  
The H. polygyrus model of rapid expulsion has many disadvantages.  
The extensive intestinal changes due to inflammation makes it difficult to 
determine what part of the immune response is specifically promoting rapid 
expulsion.  Furthermore, the protection provided by passive immunization with 
antibodies in this model is limited and the model does not replicate all known 
parameters of rapid expulsion induced by natural infection.  Because of these 
disadvantages, we decided to characterize another model of rapid expulsion, 
that induced by parenteral infection. 
Parenteral infection with T. spiralis newborn larvae (NBL) elicits a 
protective response that is equivalent to that of natural infection.  We 
confirmed that protection provided by parenteral immunization was specific for 
the infectious first-stage larva and displayed kinetics consistent with rapid 
expulsion.  Like rapid expulsion induced by oral infection with T. spiralis, 
parenteral infection promoted mucus entrapment of larvae.  Parenteral 
infection did not cause eosinophilia, mastocytosis, or goblet cell hyperplasia of 
the small intestine.  Thus parenteral infection eliminated the confounding 
inflammatory changes in the intestine due to oral infection.  Despite the 
absence of intestinal mastocytosis, mast cells were activated coincident with 
expulsion.  It would be informative to treat parenterally infected rats with 
doxantrazole, a mast cell stabilizer, prior to challenge to determine whether 
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mast cells effect rapid expulsion in this model of protection.  Isotypes induced 
by parenteral infection reflect a modified Th2 profile associated with chronic 
parasite infections (22).  IgG1 and IgG2a were dominant with little IgE in 
parenterally infected rats, while IgG1 and IgE were elevated in orally infected 
rats.  Because IgG1 was elevated in both models of infection, and because 
this isotype causes mucus entrapment in neonatal rats and in vitro, it is likely 
that this isotype mediated mucus entrapment in parenterally infected rats.  IgE 
and IgG2a are either not essential, or they play compensatory roles in 
effecting rapid expulsion.  To address this question, parenterally infected nude 
rats could be passively transferred with parasite specific IgG2a and IgE prior 
to challenge infection.  In addition, complement was not essential for rapid 
expulsion in parenterally infected rats. 
In the absence of inflammatory and architectural changes in the 
intestine, parenteral infection must induce more subtle alterations in the 
intestinal environment that promote the protective effects of antibodies.  It is 
likely that muscle larvae residing in the tongue provide an antigenic stimulus at 
a mucosal site.  T cells, primed at this location, may up-regulate homing 
molecules such as α4β7 and CCR9 or αEβ7 that direct migration to the 
intestine (10).  The integrin α4β7 binds MadCAM-1 and is important for T cell 
entry into the lamina propria, while the chemokine receptor, CCR9 binds 
TECK and localizes T-cells to the small intestinal epithelium (20).  The integrin 
αEβ7 is expressed on many mucosal T cells, and it ligand is E-cadherin.  
Alternatively, since parenteral immunization establishes a persistent muscle 
infection (60 days in our experiments), systemic activation of lymphocytes 
might also induce trafficking to mucosal sites.  Activated T cells migrating to 
the intestine might then influence intestinal cells by producing cytokines.  
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While mast cell numbers are not increased, they become activated during 
expulsion.  It is possible that the Th2 cytokines released by T-cells might alter 
the resident mast cell FcR expression to a higher A/I ratio making these cells 
more responsive to stimulation by either IgE or IgG2a immune complexes.  
RMCP-II release causes increased paracellular permeability in the intestine 
(19), and this would facilitate IgG1 transport to the lumen.  Thus IgG1 provides 
protection by encumbrance of larvae within the intestinal epithelium.  This 
model of protection induced by parenteral immunization is depicted in Figure 
5.1.  T. spiralis provides an excellent system to further investigate mucosal 
immunity induced by parenteral immunization.   
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Figure 5.1:  Model of immunity induced by parenteral immunization.  
(1)  T cells activated by muscle larvae residing in the tongue 
upregulate expression of α4β7 and CCR9.  These cells migrate to the 
intestine where they release Th2 cytokines that influence resident 
mast cells.  (2)  Upon re-infection, mast cells, activated by either IgE or 
IgG2a complexed with parasite antigen, release RMCP-II.  (3)  RMCP-
II increases intestinal paracellular permeability and aids translocation 
of parasite specific IgG1 to the gut.  (4)  IgG1 mediates mucus 
entrapment of larvae.  (5)  IgG1 encumbers larvae within the 
epithelium and blocks their sensory reception that impedes epithelial 
invasion.  
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